John Chalmers

Q: What Schools Are Affiliated With John Chalmers

John Chalmers is affiliated with the following schools: Massachusetts General Hospital, Nanjing Medical University, Peking University, Monash University, University of Lausanne, University of New South Wales, University of Sydney, University of Melbourne, RMIT University, Massachusetts Institute of Technology, Royal Postgraduate Medical School

John Chalmers 's AcademicInfluence.com Rankings

John Chalmers

Law

#1223

World Rank

#1559

Historical Rank

Common Law

#17

World Rank

#19

Historical Rank

law Degrees

Download Badge

John Chalmers 's Degrees

Masters Medical Research University of Melbourne

Why Is John Chalmers Influential?

(Suggest an Edit or Addition)

According to Wikipedia, John Philip Chalmers is an Australian medical researcher, best known for his work in the field of cardiovascular physiology, specifically for his research into hypertension. He is an Emeritus Professor of Medicine at both the University of Sydney and Flinders University in Adelaide and a professor of medicine at the University of New South Wales in Sydney. Chalmers is also a senior director at the George Institute for Global Health.

(See a Problem?)

John Chalmers 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. (1999) (2627)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack (2001) (2412)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis (2016) (2132)
Severe hypoglycemia and risks of vascular events and death. (2010) (1317)
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. (2013) (1161)
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis (2012) (944)
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. (2003) (930)
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. (2014) (923)
Intensive glucose control and macrovascular outcomes in type 2 diabetes (2009) (892)
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) (841)
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis (2016) (826)
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. (2005) (810)
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis (2010) (801)
Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial (2008) (727)
Clinical Practice Guidelines for the Management of Hypertension in the Community (2014) (726)
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials (2008) (686)
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
Prevalence, Awareness, Treatment, and Control of Hypertension in China: Data from the China National Nutrition and Health Survey 2002 (2008) (490)
Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy (2005) (445)
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. (2015) (423)
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
The management of fresh ruptures of the tendo achillis. (1970) (377)
Brain amines and models of experimental hypertension. (1975) (352)
1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. (2016) (324)
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes (2014) (322)
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. (2017) (315)
Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system (2007) (314)
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial (2006) (308)
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds (2012) (297)
Cancellous bone: its strength and changes with aging and an evaluation of some methods for measuring its mineral content. (1966) (279)
Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study (2012) (278)
Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial (2014) (266)
Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes (2009) (265)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. (1991) (259)
Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial (2003) (253)
Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
Rupture of the calcaneal tendon. The early and late management. (1987) (250)
UKPDS and the legacy effect. (2008) (228)
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. (2008) (226)
Effects of Early Intensive Blood Pressure-Lowering Treatment on the Growth of Hematoma and Perihematomal Edema in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT) (2010) (223)
Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. (2015) (221)
Peripheral compression lesions of the ulnar nerve. (1968) (219)
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials (2011) (203)
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials (2013) (203)
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. (2009) (202)
The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis (2008) (199)
Mobile Phone Apps to Improve Medication Adherence: A Systematic Stepwise Process to Identify High-Quality Apps (2016) (197)
International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. (2003) (191)
Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study (2010) (190)
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial (2010) (188)
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2009) (187)
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON (2016) (185)
Hematoma growth and outcomes in intracerebral hemorrhage (2012) (184)
Osteomalacia--a common disease in elderly women. (1967) (183)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2013) (177)
Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial (2014) (172)
Transplantation immunity in bone homografting. (1959) (170)
Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis (2011) (166)
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. (2010) (166)
World health organisation-international society of hypertension (WHO/ISH) hypertension guidelines. (2004) (165)
Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. (1986) (165)
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
Genomewide Association Study Using a High-Density Single Nucleotide Polymorphism Array and Case-Control Design Identifies a Novel Essential Hypertension Susceptibility Locus in the Promoter Region of Endothelial NO Synthase (2012) (163)
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus (2016) (161)
Significance of perihematomal edema in acute intracerebral hemorrhage (2009) (159)
Participation of Central Noradrenergic Neurons in Arterial Baroreceptor Reflexes in the Rabbit (1971) (158)
1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
Calcium, Parathyroid Hormone and the Calcitonins (1973) (150)
Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke (2008) (145)
Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study) (2010) (145)
Geographical variations in senile osteoporosis. The association with physical activity. (1970) (144)
Illuminating dark networks: a social network analysis of an Australian drug trafficking syndicate (2012) (141)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study (2014) (137)
Proteinuria and stroke: a meta-analysis of cohort studies. (2009) (136)
The ACE Gene I/D Polymorphism Is Not Associated With the Blood Pressure and Cardiovascular Benefits of ACE Inhibition (2003) (136)
Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis (2010) (135)
Different populations of parvalbumin‐ and calbindin‐D28k‐immunoreactive neurons contain GABA and accumulate 3H‐D‐aspartate in the dorsal horn of the rat spinal cord (1991) (134)
Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. (2004) (132)
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial (2018) (132)
Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE (2011) (131)
The Second (Main) Phase of an Open, Randomised, Multicentre Study to Investigate the Effectiveness of an Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (Interact2) (2010) (131)
Prognostic Significance of Perihematomal Edema in Acute Intracerebral Hemorrhage: Pooled Analysis From the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies (2015) (126)
Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke (2005) (125)
Contemporary model for cardiovascular risk prediction in people with type 2 diabetes (2011) (123)
Hypertension, Bradycardia, and Pulmonary Edema in the Conscious Rabbit after Brainstem Lesions Coinciding with the A1 Group of Catecholamine Neurons (1981) (123)
Participation of Central Noradrenergic Neurons in Arterial Baroreceptor Reflexes in the Rabbit: A STUDY WITH INTRACISTERNALLY ADMINISTERED 6‐HYDROXYDOPAMINE (1972) (123)
Mortality patterns in hypertension (2011) (122)
Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes (2015) (121)
Catecholamines and stress: Recent advances edited by Earl Usdin, Richard Kvetnansky and Irwin J. Kopin, Elsevier/North-Holland, 1980. $65.00 (U.S.A.) $72.25 (rest of world) (xxv + 618 pages) ISBN 0 444 00402 5 (1982) (120)
Separate areas of rat medulla oblongata with populations of serotonin- and adrenaline-containing neurons alter blood pressure after L-glutamate stimulation. (1987) (117)
Evidence for an excitatory amino acid pathway in the brainstem and for its involvement in cardiovascular control (1989) (116)
The relative roles of the aortic and carotid sinus nerves in the rabbit in the control of respiration and circulation during arterial hypoxia and hypercapnia (1967) (115)
Genome-wide association study of kidney function decline in individuals of European descent (2014) (114)
The value of remanipulating Colles' fractures. (1986) (112)
Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort Study (2013) (109)
Oral Disease in Relation to Future Risk of Dementia and Cognitive Decline: Prospective Cohort Study Based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (Advance) Trial (2013) (109)
Glutamate-immunoreactive synapses on retrogradely-labelled sympathetic preganglionic neurons in rat thoracic spinal cord (1992) (106)
Australian National Health and Medical Research Council dietary salt study in mild hypertension. (1986) (106)
Prediction of kidney-related outcomes in patients with type 2 diabetes. (2012) (106)
APOE genotype, ethnicity, and the risk of cerebral hemorrhage (2008) (105)
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. (2007) (104)
Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History (2009) (102)
Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data (2019) (100)
Effects of clonidine on the baroreceptor-heart rate reflex and on single aortic baroreceptor fibre discharge. (1974) (99)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
Spinal cord serotonin release and raised blood pressure after braintem kainic acid injection (1986) (99)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis (2012) (98)
Differential expression of catecholamine biosynthetic enzymes in the rat ventrolateral medulla (2001) (98)
Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus (2012) (97)
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study (2016) (95)
Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study (2014) (95)
Effects of L-dopa on norepinephrine metabolism in the brain. (1971) (93)
The 1999 WHO–ISH Guidelines for the Management of Hypertension (1999) (93)
Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy (2012) (93)
International Society of Hypertension (ISH): Statement on Blood Pressure Lowering and Stroke Prevention (2003) (93)
The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. (2000) (91)
Glutamate in spinally projecting neurons of the rostral ventral medulla (1991) (90)
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. (2010) (89)
eHealth Literacy: Predictors in a Population With Moderate-to-High Cardiovascular Risk (2017) (89)
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack (2005) (89)
Placebo‐Controlled Study of Lisinopril in Congestive Heart Failure: A Multicentre Study (1987) (86)
Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. (1984) (85)
Salt intake assessed by 24 h urinary sodium excretion in a random and opportunistic sample in Australia (2014) (84)
Intracerebral hemorrhage location and outcome among INTERACT2 participants (2017) (82)
One year comparative trial of metformin and glipizide in type 2 diabetes mellitus. (1994) (82)
Altered c-fos in rostral medulla and spinal cord of spontaneously hypertensive rats. (1996) (82)
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention. (2018) (82)
Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease (2005) (81)
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. (2010) (81)
Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study. (2016) (80)
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. (2010) (79)
Plasma Neuropeptide Y Concentration Is Increased After Hemorrhage in Conscious Rats: Relative Contributions of Sympathetic Nerves and the Adrenal Medulla (1987) (79)
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review (2017) (78)
Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure (2019) (78)
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes (2016) (78)
Optimal achieved blood pressure in acute intracerebral hemorrhage (2015) (78)
Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE (2009) (77)
Reductions in the risks of recurrent stroke in patients with and without diabetes: The PROGRESS Trial (2004) (76)
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses (2020) (75)
The Biochemistry and Physiology of Bone (1973) (75)
The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes (2014) (75)
Kidney measures beyond traditional risk factors for cardiovascular prediction: A collaborative meta-analysis (2015) (75)
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. (2003) (74)
Rationale, Design, and Progress of the ENhanced Control of Hypertension ANd Thrombolysis Stroke Study (ENCHANTED) Trial: An International Multicenter 2 × 2 Quasi-Factorial Randomized Controlled Trial of Low- vs. Standard-Dose rt-PA and Early Intensive vs. Guideline-Recommended Blood Pressure Lowerin (2015) (74)
A randomised study of outcomes in a defined group of acutely ill elderly patients managed in a geriatric assessment unit or a general medical unit. (1991) (74)
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study (2016) (73)
Is poor oral health a risk marker for incident cardiovascular disease hospitalisation and all-cause mortality? Findings from 172 630 participants from the prospective 45 and Up Study (2016) (73)
Nervous system and hypertension. (1978) (72)
Arterial Baroreceptor Reflex Function in the Conscious Rabbit after Brainstem Lesions Coinciding with the Al Group of Catecholamine Neurons (1981) (72)
Quantitative analysis of spinally projecting adrenaline-synthesising neurons of C1, C2 and C3 groups in rat medulla oblongata. (1990) (70)
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes (2017) (69)
The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion (2014) (69)
Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. (2016) (69)
Substance P immunoreactive boutons form synapses with feline sympathetic preganglionic neurons (1992) (68)
Central inspiration increases barosensitivity of neurons in rat rostral ventrolateral medulla. (1995) (68)
Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial (2013) (68)
Close appositions between Tyrosine hydroxylase immunoreactive boutons and respiratory neurons in the rat ventrolateral medulla (1994) (68)
Part-time Work and Caring Responsibilities in Australia: Towards an Assessment of Job Quality (2005) (67)
The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes (2013) (66)
ADVANCE—Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline (2005) (66)
Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial (2006) (66)
The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus (2013) (65)
How Have Patients Reacted to the Implications of the DCCT? (1996) (63)
Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies (2016) (63)
Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage (2010) (63)
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. (2009) (62)
Examination of an eHealth literacy scale and a health literacy scale in a population with moderate to high cardiovascular risk: Rasch analyses (2017) (62)
Participation of Central Serotonergic Neurons in the Control of the Circulation of the Unanesthetized Rabbit: A Study Using 5, 6‐Dihydroxytryptamine In Experimental Neurogenic And Renal Hypertension (1974) (62)
Optimal size of cuff bladder for indirect measurement of arterial pressure in adults. (1989) (62)
The one hundred percent hypothesis: glutamate or GABA in synapses on sympathetic preganglionic neurons. (1995) (62)
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
Release of substance P in the nucleus tractus solitarius measured by in vivo microdialysis: response to stimulation of the aortic depressor nerves in rabbit (1988) (62)
Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes (2015) (61)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
Bötzinger neurons project towards bulbospinal neurons in the rostral ventrolateral medulla of the rat (1997) (59)
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial (2018) (59)
Plasma Catecholamines and Neuropeptide‐Y as Indices of Sympathetic Nerve Activity in Normotensive and Stroke‐Prone Spontaneously Hypertensive Rats (1986) (59)
Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study. (2015) (59)
Role of excitatory amino acid receptors in cardiorespiratory coupling in ventrolateral medulla. (1996) (59)
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data (2018) (59)
N-Glycan Profile and Kidney Disease in Type 1 Diabetes (2017) (59)
Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus (2012) (58)
Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage (2016) (56)
Removal of metal implants after fracture surgery--indications and complications. (1993) (56)
An enkephalin-containing pathway from nucleus tractus solitarius to the pressor area of the rostral ventrolateral medulla of the rabbit (1989) (56)
Blood pressure variability and outcome after acute intracerebral haemorrhage : a post-hoc analysis of INTERACT 2 , a randomised controlled trial * (2014) (56)
N‐METHYL‐d‐ASPARTATE RECEPTORS IN THE SPINAL CORD MEDIATE PRESSOR RESPONSES TO STIMULATION OF THE ROSTRAL VENTROLATERAL MEDULLA IN THE RAT (1988) (56)
The 1996 report of a World Health Organization expert committee on hypertension control. (1996) (56)
c‐fos identifies GABA‐synthesizing barosensitive neurons in caudal ventrolateral medulla (1997) (55)
Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial (2014) (55)
Impending global pandemic of cardiovascular diseases (1999) (55)
Baseline Cognitive Function, Recurrent Stroke, and Risk of Dementia in Patients With Stroke (2013) (55)
Local and reflex factors affecting the distribution of the peripheral blood flow during arterial hypoxia in the rabbit (1967) (54)
Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). (2012) (54)
c-fos antisense in rostral ventral medulla reduces arterial blood pressure. (1994) (52)
EFFECTS OF TIMOLOL AND HYDROCHLOROTHIAZIDE ON BLOOD-PRESSURE AND PLASMA RENIN ACTIVITY Double-blind Factorial Trial (1976) (52)
Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta‐analysis of randomized controlled trials (2010) (51)
Investigation of antihypertensive class, dementia, and cognitive decline (2019) (51)
Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study (2017) (51)
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. (2013) (50)
Sex differences in treatment and outcome after stroke (2019) (50)
Significance of Hematoma Shape and Density in Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial Study (2016) (50)
Participation of Adrenergic and Noradrenergic Neurones in Central Connections of Arterial Baroreceptor Reflexes in the Rat (1979) (50)
Does substance P coexist with adrenaline in neurones of the rostral ventrolateral medulla in the rat? (1986) (49)
Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial (2018) (49)
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region (2004) (49)
Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial (2012) (49)
Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic? (2011) (49)
The effects of haemorrhage in the unanaesthetized rabbit (1967) (48)
Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus. (2019) (47)
The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. (2014) (47)
Amino acid neurotransmitters in the central control of blood pressure and in experimental hypertension. (1992) (47)
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals (2011) (47)
Moving from Unemployment to Permanent Employment: Could a Casual Job Accelerate the Transition? (2001) (47)
Earlier Blood Pressure-Lowering and Greater Attenuation of Hematoma Growth in Acute Intracerebral Hemorrhage: INTERACT Pilot Phase (2012) (46)
Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial (2012) (46)
The role of the sympathetic nervous system in the circulatory response of the rabbit to arterial hypoxia. (1965) (46)
The place of combination therapy in the treatment of hypertension in 1993. (1993) (46)
Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials (2016) (45)
Automated non-invasive measurement of cardiac output: comparison of electrical bioimpedance and carbon dioxide rebreathing techniques. (1988) (45)
The Direct and Indirect Effects of Unemployment on Poverty and Inequality (2003) (45)
ADVANCE: action in diabetes and vascular disease (2005) (45)
Renal sympathetic nerve responses to stimulation, inhibition and destruction of the ventrolateral medulla in the rabbit (1985) (44)
Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. (2005) (44)
MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: a randomised controlled trial protocol (2017) (44)
Effect of Intrathecal Amino Acid Receptor Antagonists on Basal Blood Pressure and Pressor Responses to Brainstem Stimulation in Normotensive and Hypertensive Rats (1990) (44)
Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results (2016) (44)
Blood pressure lowering for the secondary prevention of myocardial infarction and stroke. (1997) (44)
Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease (2005) (44)
Mannitol and Outcome in Intracerebral Hemorrhage: Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results (2015) (44)
Intensive glucose control and risk of cancer in patients with type 2 diabetes (2011) (43)
Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial (2010) (43)
Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination. (1988) (43)
uantitative measurements of osteoid in health and disease. (1969) (43)
Revisiting lifestyle risk index assessment in a large Australian sample: should sedentary behavior and sleep be included as additional risk factors? (2014) (43)
The action of clonidine on the baroreflex control of heart rate in conscious animals and man, and on single aortic baroreceptor discharge in the rabbit. (1975) (43)
Exercise testing before and after hip arthroplasty. (1980) (42)
Lack of effect of fish oil supplementation on blood pressure in treated hypertensives. (1990) (42)
The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia. (2016) (42)
Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study) (2017) (42)
KYNURENIC ACID, AN ENDOGENOUS GLUTAMATE ANTAGONIST, IN SHR AND WKY RATS: POSSIBLE ROLE IN CENTRAL BLOOD PRESSURE REGULATION (1994) (42)
Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. (2006) (41)
1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1989) (41)
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON (2017) (41)
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial (2021) (41)
PROGRESS: Prevention of Recurrent Stroke (2011) (41)
Towards a Credible Poverty Framework : From Income Poverty to Deprivation (2004) (41)
Abnormal Insulin Treatment Behaviour: a Major Cause of Ketoacidosis in the Young Adult (1995) (40)
PLASMA NEUROPEPTIDE Y LEVELS RISE IN PATIENTS UNDERGOING EXERCISE TESTS FOR THE INVESTIGATION OF CHEST PAIN (1986) (40)
Mild hypertension: A summary of the 1993 World Health Organization/International Society of Hypertension (WHO/ISH) guidelines for the management of mild hypertension Memorandum from a WHO/ISH meeting † (1994) (40)
Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study. (2015) (40)
Statistical analysis plan for evaluating low‐ vs. standard‐dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED) (2015) (40)
Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial. (2008) (40)
Role of AMPA/kainate receptors in transmission of the sympathetic baroreflex in rat CVLM. (1997) (39)
Intracellular recording from sympathetic preganglionic neurons in cat lumbar spinal cord (1994) (39)
Real or perceived impediments to minimum pricing of alcohol in Australia: public opinion, the industry and the law. (2013) (39)
Central control of blood pressure. (1992) (39)
The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial. (2010) (39)
The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study (2018) (39)
Sex difference in the relationship of calcium and magnesium excretion to glycaemic control in type 1 diabetes mellitus. (1999) (39)
GABA- and glutamate-immunoreactive synapses on sympathetic preganglionic neurons projecting to the superior cervical ganglion. (1998) (38)
Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta‐analysis consisting 2.8 million adults with 57 294 cases of dementia (2020) (38)
Cancellous bone: its strength and changes with aging and an evaluation of some methods for measuring its mineral content.II. An evaluation of some methods for measuring osteoporosis. (1966) (38)
Efficacy and Safety of Quarter-Dose Blood Pressure–Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2017) (38)
Round table 2. First-line drugs: the position of the World Health Organization-International Society of Hypertension. (1993) (38)
Effects of different blood pressure lowering regimens on major cardiovascular events: second cycle of prospectively designed overviews (2003) (38)
Projections from inspiratory neurons of the ventral respiratory group to the subretroficial nucleus of the cat (1994) (38)
Ventral medulla stimulation increases blood pressure and spinal cord amino acid release. (1992) (38)
Effects of arterial hypoxia on the cutaneous circulation of the rabbit (1966) (38)
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2018) (38)
Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor. (1998) (38)
Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain. (1972) (37)
Serotonin inputs to rabbit sympathetic preganglionic neurons projecting to the superior cervical ganglion or adrenal medulla (1995) (37)
Global survey of current practice in management of hypertension as reported by societies affiliated with the international society of hypertension (2013) (37)
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (37)
Disinhibition of the rostral ventral medulla increases blood pressure and Fos expression in bulbospinal neurons (1994) (37)
Endothelial Gata5 transcription factor regulates blood pressure (2015) (36)
Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial (2010) (36)
Comparative policy analysis for alcohol and drugs: Current state of the field. (2016) (36)
Job quality and part-time work in the retail industry: An Australian case study (2008) (36)
Social network analysis of Australian poly-drug trafficking networks: How do drug traffickers manage multiple illicit drugs? (2017) (36)
The Association with Physical Activity (1970) (36)
Dietary Salt Intake and Discretionary Salt Use in Two General Population Samples in Australia: 2011 and 2014 (2015) (36)
Calbindin‐immunoreactive neurons in the reticular formation of the rat brainstem: Catecholamine content and spinal projections (2000) (36)
Neuropeptide Y-immunoreactive synapses in the intermediolateral cell column of rat and rabbit thoracic spinal cord (1990) (36)
The importance of central adrenergic neurones in renal hypertension in rabbits (1974) (36)
Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial (2017) (36)
Sympathetic preganglionic neurons in rabbit spinal cord that project to the stellate or the superior cervical ganglion (1992) (35)
Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes (2016) (35)
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan. (2004) (35)
Inhibition of vasodepressor neurons in the caudal ventrolateral medulla of the rabbit increases both arterial pressure and the release of neuropeptide Y-like immunoreactivity from the spinal cord (1987) (35)
The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial (2016) (35)
Automated non-invasive measurement of cardiac output by the carbon dioxide rebreathing method: comparisons with dye dilution and thermodilution. (1990) (35)
Autonomic blockade and the Valsalva maneuver in patients on maintenance hemodialysis: a hemodynamic study. (1977) (35)
CENTRAL NEURONS AND NEUROTRANSMITTERS IN THE CONTROL OF BLOOD PRESSURE (1994) (35)
International Society of Hypertension (ISH): Statement on blood pressure lowering and stroke prevention - International Society of Hypertension Writing Group (2003) (34)
Role of the Autonomic Nervous System in the Renal Vasoconstriction Response to Hemorrhage in the Rabbit (1967) (34)
Associations between body mass index and the risk of renal events in patients with type 2 diabetes (2018) (34)
Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial* (2011) (34)
The effect of methamphetamine and heroin price on polydrug use: A behavioural economics analysis in Sydney, Australia. (2010) (34)
Marginalising Women in the Labour Market: 'Wage Scarring' Effects of Part-time Work (2007) (34)
The control of the circulation in skeletal muscle during arterial hypoxia in the rabbit (1966) (33)
Bulbospinal neuropeptide Y-immunoreactive neurons in the rat: comparison with adrenaline-synthesising neurons. (1994) (33)
Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World? (2011) (33)
Challenges for the Prevention of Primary and Secondary Stroke. The importance of lowering blood pressure and total cardiovascular risk (2001) (33)
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial (2010) (33)
Recreational drug use and binge drinking: stimulant but not cannabis intoxication is associated with excessive alcohol consumption. (2014) (33)
Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study. (1986) (32)
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis (2021) (32)
Bulbospinal sympatho‐excitatory neurons in the rat caudal raphe (1995) (32)
Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage: Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies* (2016) (32)
Preferential release of neuroactive amino acids from the ventrolateral medulla of the rat in vivo as measured by microdialysis (1990) (32)
Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications (2020) (32)
Effects of Vasopressin on Heart Rate in Conscious Rabbits (1985) (32)
C-fos expression in central neurons mediating the arterial baroreceptor reflex. (1997) (32)
Antisense to thyrotropin releasing hormone receptor reduces arterial blood pressure in spontaneously hypertensive rats. (1995) (32)
White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial (2016) (31)
Measuring Unmet Demand for Alcohol and Other Drug Treatment: The Application of an Australian Population-Based Planning Model (2019) (31)
Association between alcohol consumption and diabetic retinopathy and visual acuity—the AdRem Study (2010) (31)
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes (2016) (31)
Effect of lateral hypothalamic lesions on uptake of norepinephrine by brain homogenates. (1971) (30)
Sensitive topics in social research involving children (2018) (30)
Significance of Intraventricular Hemorrhage in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Results (2015) (30)
The risk of cancer in people with diabetes and chronic kidney disease. (2012) (30)
THE EFFECTS OF INDOMETHACIN IN TREATED HYPERTENSIVE PATIENTS (1981) (30)
Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage. (2019) (30)
Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular Disease: A Randomized Controlled Trial (2003) (30)
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study (2019) (30)
Effects of sinoaortic baroreceptor denervation on blood pressure and PNMT activity in medulla oblongata and spinal cord of normotensive and genetically hypertensive rats. (1985) (30)
Synapses on axons of sympathetic preganglionic neurons in rat and rabbit thoracic spinal cord (1995) (29)
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. (2012) (29)
Activation of spinal opioid receptors contributes to hypotension after hemorrhage in conscious rats. (1999) (29)
AMPA/kainate receptors mediate sympathetic chemoreceptor reflex in the rostral ventrolateral medulla (1996) (29)
Changes in Cardiac Norepinephrine in Spontaneously Hypertensive and Stroke‐Prone Rats (1979) (29)
Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial (2014) (29)
Effects of haemorrhage on the distribution of the peripheral blood flow in the rabbit (1967) (29)
Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials (2019) (29)
Hypertension in the elderly: the role of calcium antagonists. (1988) (29)
Effects of a community-based salt reduction program in a regional Australian population (2016) (29)
Importance of new catecholamine pathways in control of blood pressure. (1981) (28)
Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes (2019) (28)
EFFECTS OF P‐CHLOROPHENYLALANINE ON BLOOD PRESSURE AND HEART RATE IN NORMAL RABBITS AND RABBITS WITH NEUROGENIC HYPERTENSION (1974) (28)
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial (2017) (28)
Local thermodilution method for measuring blood flow in the portal and renal veins of the unanaesthetized rabbit. (1967) (28)
Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand (2019) (28)
More than problem-solving: critical reflections on the 'problematisation' of alcohol-related violence in Kings Cross. (2012) (28)
Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis (2017) (28)
GLP-1 receptor agonists in type 2 diabetes - NICE guidelines versus clinical practice (2014) (28)
Effects of the End Point Adjudication Process on the Results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) (2009) (28)
Housing, location and employment (2003) (27)
Prevalence, Awareness, Treatment, and Control of Hypertension in China (2008) (27)
Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study (2018) (27)
MICROINJECTION OF KAINIC ACID INTO THE ROSTRAL VENTROLATERAL MEDULLA CAUSES HYPERTENSION AND RELEASE OF NEUROPEPTIDE Y‐LIKE IMMUNOREACTIVITY FROM RABBIT SPINAL CORD (1987) (27)
Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline. (2020) (27)
Cardiovascular effects of opioid antagonist naloxone in rostral ventrolateral medulla of rabbits. (1990) (27)
The fate of intracisternally administered norepinephrine-3H in the brain and spinal cord of the rabbit. (1971) (27)
Review Article: Treatment of Achilles Tendon Ruptures (2000) (26)
Central serotonergic mechanisms in hypertension. (1988) (26)
The speed of ultraearly hematoma growth in acute intracerebral hemorrhage (2014) (26)
Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies (2016) (26)
Importance of Blood Pressure Lowering in Type 2 Diabetes: Focus on ADVANCE (2010) (26)
Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage (2015) (26)
Different types of centrally acting antihypertensives and their targets in the central nervous system (1994) (26)
Neurokinin-1 receptor-immunoreactive sympathetic preganglionic neurons: target specificity and ultrastructure (1997) (26)
Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database (2018) (26)
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC) (2019) (26)
Leakage of dl-propranolol from cerebrospinal fluid to the bloodstream in the rabbit. (1977) (26)
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes. (2019) (25)
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage. (2016) (25)
PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study (2017) (25)
Audit of major gastrointestinal surgery in patients aged 80 years or over. (1994) (25)
Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease (2016) (25)
A simple, sensitive method for the determination of extracellular catecholamines in the rat hypothalamus using in vivo dialysis (1987) (24)
What are the options? pricing and taxation policy reforms to redress excessive alcohol consumption and related harms in australia (2011) (24)
Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population. (2016) (24)
Yoga’s effect on inflammatory biomarkers and metabolic risk factors in a high risk population – a controlled trial in primary care (2015) (24)
The lowering of blood pressure after stroke (2001) (24)
Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study (2011) (24)
Dietary salt intake in the Australian population (2017) (24)
Baroreflex control of myocardial contractility in conscious normotensive and renal hypertensive rabbits. (1983) (24)
Some Mechanisms of Reflex Control of the Circulation by the Sympatho‐adrenal System (1967) (24)
Effects of olfactory bulb lesions on brain monoamines. (1971) (24)
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials (2017) (23)
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes (2020) (23)
Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation (2003) (23)
Importance of central catecholaminergic neurones in the development and maintenance of renal hypertension. (1973) (23)
Poor Utility of Grading Scales in Acute Intracerebral Hemorrhage: Results from the Interact2 Trial (2015) (22)
Subarachnoid Extension of Intracerebral Hemorrhage and 90-Day Outcomes in INTERACT2 (2014) (22)
The impact of level of education on vascular events and mortality in patients with type 2 diabetes mellitus: Results from the ADVANCE study. (2017) (22)
Delayed diagnosis of juvenile primary hyperparathyroidism. (1996) (22)
Disparities between Prescribing of Secondary Prevention Therapies for Stroke and Coronary Artery Disease in General Practice (2012) (22)
ADVANCE: breaking new ground in type 2 diabetes (2006) (22)
Prevention of cardiovascular diseases in developing countries: agenda for action (statement from a WHO-ISH Meeting in Beijing, October 1999). (2000) (22)
Associations with health-related quality of life after intracerebral haemorrhage: pooled analysis of INTERACT studies (2016) (21)
‘User pays’ and other approaches to the funding of long-term care for older people in Australia (2000) (21)
Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit. (1989) (21)
Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial (2018) (21)
Blood Pressure Lowering for the Prevention of Cognitive Decline in Patients with Cerebrovascular Disease (1997) (21)
Idiopathic Ischemic Necrosis of the Femoral Head in Adults (1972) (21)
Fractures of the femoral neck in elderly patients with hyperparathyroidism. (1988) (21)
Effects of intrathecal administration of methysergide, phentolamine, and pindolol on pressor responses to electrical stimulation of the rostral ventrolateral medulla. (1988) (21)
Deconstructing alcohol use on a night out in England: promotions, preloading and consumption. (2014) (21)
Demethylation of 3-O-methyldopa in the rat (1971) (20)
Prognostic significance of delayed intraventricular haemorrhage in the INTERACT studies (2016) (20)
Distribution of peripheral blood flow in primary tissue hypoxia induced by inhalation of carbon monoxide (1967) (20)
Tonic opioid inhibition of the pressor region of the rostral ventrolateral medulla of rabbits is mediated by delta receptors. (1990) (20)
International Society of Hypertension (ISH): statements on blood pressure and stroke (2003) (20)
Differences in the Central Hypotensive Actions of α‐Methyldopa and Clonidine in the Spontaneously Hypertensive Rat: Contribution of Neurons Arising from the B3 and the Cl Areas of the Rostral Ventrolateral Medulla (1990) (20)
Assessment of cardiac autonomic excitability in renal hypertensive rabbits using clonidine-induced resetting of the baroreceptor-heart rate reflex. (1975) (20)
Prediction of 10‐year vascular risk in patients with diabetes: the AD‐ON risk score (2016) (20)
Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects. (1989) (20)
Trials on blood pressure-lowering and secondary stroke prevention. (2003) (20)
Thyrotropin-releasing hormone immunoreactive boutons form close appositions with medullary expiratory neurons in the rat (1996) (20)
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial (2014) (20)
The business cycle and drug use in Australia: evidence from repeated cross-sections of individual level data. (2011) (20)
The effects of reduced copayments on discontinuation and adherence failure to statin medication in Australia. (2015) (20)
The role of central catecholamines in the control of blood pressure through the baroreceptor reflex and the nasopharyngeal reflex in the rabbit. (1977) (20)
Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study (2016) (19)
Medication Discrepancies in Discharge Summaries and Associated Risk Factors for Elderly Patients with Many Drugs (2019) (19)
Amino acid neurotransmitters in hypertension. (1992) (19)
Content and turnover of noradrenaline in spinal cord and cerebellum of spontaneously hypertensive and stroke-prone rats. (1981) (19)
Impact of a short home-based yoga programme on blood pressure in patients with hypertension: a randomized controlled trial in primary care (2016) (19)
Governing the Heroin Trade: From Treaties to Treatment (2009) (19)
Subsidising patient dispensing fees: the cost of injecting equity into the opioid pharmacotherapy maintenance system. (2012) (18)
BLOOD PRESSURE LOWERING IN PATIENTS WITH CEREBROVASCULAR DISEASE: RESULTS OF THE PROGRESS (PERINDOPRIL PROTECTION AGAINST RECURRENT STROKE STUDY) PILOT PHASE (1996) (18)
Are the ventrally projecting dendrites of respiratory neurons a neuroanatomical basis for the chemosensitivity of the ventral medulla oblongata? (1993) (18)
Enhancing risk stratification in hypertensive subjects: how far should we go in routine screening for target organ damage? (2002) (18)
Central serotonergic mechanisms in cardiovascular regulation (2004) (18)
Central serotonin and cardiovascular control. (1975) (18)
Effects of the angiotensin receptor blocker, telmisartan, on cardiovascular events in high-risk patients intolerant to ACE-inhibitors. Erratum of Vol 372(9644):1174-83 (2008) (18)
Relative importance of sympathetic nerves and of circulating adrenaline and vasopressin in mediating hypertension after lesions of the caudal ventrolateral medulla in the rat. (1986) (18)
Delta pioid receptor immunoreactive boutons appose bulbospinal CI neurons in the rat (2000) (18)
Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly. (1994) (18)
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. (2015) (17)
Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials. (2009) (17)
Cohort Profile: Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO). (2016) (17)
Metformin: Is its use contraindicated in the elderly? (1992) (17)
Identification of Posterior Cricoarytenoid Motoneurons in the Rat (1999) (17)
The relationship between economic conditions and substance use and harm. (2011) (17)
Methamphetamine Users’ Perceptions of Exchanging Drugs for Money (2013) (17)
Comparability of Patient-reported Health Status: Multicountry Analysis of EQ-5D Responses in Patients With Type 2 Diabetes (2011) (17)
Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy. (1990) (17)
IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke (2018) (17)
Blood pressure in acute stroke: in search of evidence. (2005) (17)
The use of microinjected colloidal gold and immunocytochemistry to localise pressor sites in the rostral medulla oblongata of the rat (1987) (17)
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (17)
Subtrochanteric fractures in osteomalacia. (1970) (17)
The availability of foster carers: main report (2004) (16)
Experimental hypertension produces diverse changes in the regional vascular responses to endothelin‐1 in the rabbit and the rat (1994) (16)
THERE ARE FEW CATECHOLAMINE‐ OR NEUROPEPTIDE Y‐CONTAINING SYNAPSES IN THE INTERMEDIOLATERAL CELL COLUMN OF RAT THORACIC SPINAL CORD (1991) (16)
Intensification of medication and glycaemic control among patients with type 2 diabetes – the ADVANCE trial (2014) (16)
Inaccurate risk perceptions contribute to treatment gaps in secondary prevention of cardiovascular disease (2016) (16)
Osteomalacia. A review of 93 cases. (1968) (16)
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS MRI Substudy (2005) (16)
Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions. (1987) (16)
Bulbospinal Serotonin Neurons and Hypotensive Effects of Methyldopa in the Spontaneously Hypertensive Rat (1984) (15)
Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis (2017) (15)
Comparative Haemodynamic Effects of Lidocaine, Mexiletine, and Disopyramide (1984) (15)
Early blood pressure lowering in patients with intracerebral haemorrhage and prior use of antithrombotic agents: pooled analysis of the INTERACT studies (2016) (15)
Clinician's Manual on Blood Pressure and Stroke Prevention (2002) (15)
Cost‐effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial‐based analysis (2010) (15)
Foster carers in New South Wales: Profile and projections based on ABS Census data (2005) (15)
Poly-drug trafficking: Estimating the scale, trends and harms at the Australian border. (2016) (15)
The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial (2021) (15)
Introduction: The global burden of stroke (2002) (15)
Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data (2021) (15)
Effects of Treatment on the Mortality Rate in Septicaemia (1969) (15)
Treatment guidelines in hypertension: current limitations and future solutions (1996) (15)
Mono- and combination therapy with felodipine or enalapril in elderly patients with systolic hypertension. (1994) (15)
Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk (2016) (15)
Spinal GABA(A) receptors do not mediate the sympathetic baroreceptor reflex in the rat. (2000) (14)
The PROGRESS trial three years later: time for more action, less distraction (2004) (14)
All hats off to ALLHAT: a massive study with clear messages (2003) (14)
Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus (2020) (14)
Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. (1992) (14)
Blood Pressure Variability and Outcome in Acute Ischemic and Hemorrhagic Stroke: A Post-Hoc Analysis of the HeadPoST Study (2019) (14)
Respiratory Activity of the Rat Posterior Cricoarytenoid Muscle (1997) (14)
The mechanism of hypertension and bradycardia following lesions of the caudal ventrolateral medulla in the rabbit: the role of sympathetic nerves, circulating adrenaline, vasopressin and renin. (1985) (14)
Children’s participation in research on sensitive topics: addressing concerns of decision-makers (2020) (14)
Endogenous opioids tonically inhibit the depressor neurones in the caudal ventrolateral medulla of rabbits: Mediation through δ- and ϰ-receptors (1991) (13)
The role of off-licence outlets in binge drinking: a survey of drinking practices last Saturday night among young adults in Australia. (2014) (13)
Frequency, determinants, and effects of early seizures after thrombolysis for acute ischemic stroke: The ENCHANTED trial (2017) (13)
Substance P-immunoreactive boutons closely appose inspiratory protruder hypoglossal motoneurons in the cat (1999) (13)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
Kainic acid injection in NTS evokes hypertension and c-fos expression in spinal cord. (1992) (13)
Using administrative data to look at changes in the level and distribution of out-of-pocket medical expenditure: An example using Medicare data from Australia. (2017) (13)
Substance P and serotonergic inputs to sympathetic preganglionic neurons. (1995) (13)
Analysis of time trends, individual subject responses and background variation in crossover factorial studies with antihypertensive drugs. (1990) (13)
AXONAL PROJECTIONS FROM RESPIRATORY CENTRES TOWARDS THE ROSTRAL VENTROLATERAL MEDULLA IN THE RAT (1992) (13)
Effects of Neuropeptide Y on the Heart and Circulation of the Conscious Rabbit (1989) (13)
Intensive glucose control in type 2 diabetes – Reply (2008) (13)
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE. (2019) (13)
Vasodepressor neurons in medulla alter cardiac contractility and cardiac output. (1993) (13)
Early Cognitive Impairment after Intracerebral Hemorrhage in the INTERACT1 Study (2017) (13)
Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes (2007) (13)
Blood pressure lowering with fixed combination perindopril–indapamide: key findings from ADVANCE (2008) (13)
Decriminalisation of drug use and possession in Australia – A briefing note. (2016) (13)
Global impact of stroke. (2000) (13)
A double blind factorial trial of pindolol and hydrochlorothiazide in hypertension (1976) (13)
Diuretics: A modern day treatment option? (Review Article) (2006) (13)
Brainstem PNMT neurons and experimental hypertension in the rat. (1984) (13)
Effect of indomethacin on blood pressure control during treatment with nitrendipine. (1995) (12)
The sympatho-adrenal system and vasopressin in cardiovascular responses to A1 lesions. (1984) (12)
Effects of neuropeptide Y on cardiac performance and renal blood flow in conscious normotensive and renal hypertensive rabbits. (1990) (12)
Following the money: Mapping the sources and funding flows of alcohol and other drug treatment in Australia. (2016) (12)
Typologies of alcohol consumption on a Saturday night among young adults. (2014) (12)
Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study (2018) (12)
Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE stuDy (2018) (12)
IMPORTANCE OF CENTRAL SEROTONIN NEURONS IN THE HYPOTENSIVE ACTION OF METHYLDOPA IN THE RAT (1984) (12)
Direct radioimmunoassay of human plasma atrial natriuretic peptide in various normal and pathophysiological states: increase in renal and cardiac failure during exercise. (1987) (12)
Neurokinin-1 receptors and spinal cord control of blood pressure in spontaneously hypertensive rats (1999) (12)
Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors (1997) (12)
Do pressor neurons in the ventrolateral medulla release amines and neuropeptides? (1987) (12)
Prophylactic heparin in acute intracerebral hemorrhage: a propensity score-matched analysis of the INTERACT2 study (2016) (12)
Recurrent common peroneal palsy in association with the Ehlers-Danlos syndrome. A case report. (1991) (12)
Erectile dysfunction in type 1 diabetic males (2008) (12)
Projection of ventrolateral medullary (A1) catecholamine neurons toward nucleus tractus solitarii (2004) (12)
Comparison of various blood pressure lowering treatments on the primary prevention of cardiovascular outcomes in recent randomised clinical trials. (2004) (11)
Immediate early genes in blood pressure regulation. (1996) (11)
Progress In Reducing The Burden Of Stroke* (2001) (11)
Is a blood pressure target of <130/80 mm Hg still appropriate for high-risk patients? (2011) (11)
Protocol for the implementation and evaluation of a community-based intervention seeking to reduce dietary salt intake in Lithgow, Australia (2014) (11)
Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatment. (2020) (11)
Intracellular Recording from Posterior Cricoarytenoid Motoneurons in the Rat (1999) (11)
Diuretics: a modern day treatment option? (2006) (11)
Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland (2021) (11)
Prevention of cardiovascular diseases in developing countries: agenda for action: statement from a WHO-ISH meeting in Beijing (1999) (11)
Infratentorial Intracerebral Hemorrhage: Relation of Location to Outcome (2019) (11)
Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension. (1985) (11)
The effect of intrathecal serotonergic antagonists on the pressor response to stimulation of the brainstem in the rat. (1989) (11)
Bulbospinal serotonin pressor pathways and hypotensive action of methyldopa in the rat. (1984) (11)
Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension. (1980) (11)
Phosphate-activated glutaminase immunoreactivity in brainstem respiratory neurons. (1997) (11)
Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA (130th American Neurological Association) (2005) (11)
Does Glycemic Control Offer Similar Benefits Among PatientsWith Diabetes in Different Regions of theWorld? Results from the ADVANCE trial (2011) (11)
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (11)
Comparison of ABC Methods with Computerized Estimates of Intracerebral Hemorrhage Volume: The INTERACT2 Study (2019) (11)
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence (2008) (11)
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review (2018) (11)
How fair is Medicare? The income‐related distribution of Medicare benefits with special focus on chronic care items (2012) (11)
Health expenditure on alcohol and other drug treatment in Australia (2012/2013). (2015) (10)
EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes (2019) (10)
Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly (1997) (10)
Is Casual Employment a 'Bridge' or a 'Trap'? (2007) (10)
EFFECTS OF NEUROPEPTIDE Y ON BAROREFLEX CONTROL OF HEART RATE AND MYOCARDIAL CONTRACTILITY IN CONSCIOUS RABBITS (1990) (10)
C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register. (2019) (10)
Sympathetic preganglionic neurons projecting to the adrenal medulla and aorticorenal ganglion in the rabbit (1992) (10)
Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studies (2017) (10)
Long-acting and short-acting diuretics in mild essential hypertension. (1982) (10)
An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event (2009) (10)
Higher mortality in patients with right hemispheric intracerebral haemorrhage: INTERACT1 and 2 (2015) (10)
Use of antidiabetic and antidepressant drugs is associated with increased risk of myocardial infarction: a nationwide register study (2015) (10)
Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial (2020) (10)
ADVANCES IN REDUCING THE BURDEN OF VASCULAR DISEASE IN TYPE 2 DIABETES (2008) (10)
The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension. (1984) (10)
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis (2020) (10)
J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: A pooled analysis of INTERACT2 and ATACH-II individual participant data (2022) (10)
EFFECTS OF NEUROPEPTIDE Y ON LEFT VENTRICULAR FUNCTION IN THE CONSCIOUS RABBIT (1987) (10)
Role of spinal GABA receptors in depressor responses to chemical stimulation of the A5 area in normal and hypertensive rats. (1997) (10)
Interactions of endogenous opioid and excitatory amino acid inputs to the caudal ventrolateral medulla of the rat (1992) (10)
Ambient Temperature and Volume of Perihematomal Edema in Acute Intracerebral Haemorrhage: The INTERACT1 Study (2015) (10)
c-fos expression in central cardiovascular pathways. (1995) (10)
Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial (2020) (9)
Are Casual Jobs a Freeway to Permanent Employment (2000) (9)
Blood pressure lowering and ACE inhibition for the avoidance of cardiac and cerebral events. (2003) (9)
Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial (2018) (9)
New Blood Pressure Guidelines Pose Difficult Choices for Australian Physicians (2019) (9)
Moving to work (2003) (9)
Role of renal nerve activity, plasma catecholamines and plasma vasopressin in cardiovascular responses to intracisternal neurotoxins in the rabbit. (1986) (9)
Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting (2004) (9)
Who will benefit more from low-dose alteplase in acute ischemic stroke? (2019) (9)
Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease (2007) (9)
Hypertension in the twentieth century: concepts and achievements (2004) (9)
Early Blood Pressure Lowering Does Not Reduce Growth of Intraventricular Hemorrhage following Acute Intracerebral Hemorrhage: Results of the INTERACT Studies (2016) (9)
Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome (2020) (9)
Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene (2017) (9)
Perindopril Protection Against Recurrent Stroke Study (PROGRESS) (2001) (9)
Changes in plasma lipids predict pravastatin efficacy in secondary prevention. (2019) (9)
Exploring interrelationships between high-level drug trafficking and other serious and organised crime: an Australian study (2020) (8)
Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm (2020) (8)
Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease (2007) (8)
Central control mechanisms in hypertension. (1997) (8)
Occupational Standing over the Life Course: What Is the Role of Part Time Work? (2013) (8)
Altered responsiveness of medullary depressor neurones to L-glutamate and D-serine in SHR rats. (1996) (8)
Impact of guidelines for antihypertensive treatment on clinical practice. (1996) (8)
Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis. (2019) (8)
Guidelines and consensus statements: their use and impact. (1995) (8)
"Treating hypertension" or "lowering blood pressure"? Extending the concept. (2002) (8)
The quality of part‐time jobs in Australia: towards an assessment (2005) (8)
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study (2020) (8)
Statistical Analysis Plan for the Second Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT2) (2013) (8)
How do methamphetamine users respond to changes in methamphetamine price (2009) (8)
The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? (2013) (8)
National service improvement framework for Heart Stroke and Vascular Disease (2005) (8)
Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension. (1976) (8)
Half a Citizen: Life on Welfare in Australia (2011) (8)
Paradoxical Inotropic Effects of Clonidine and Labetalol in the Conscious Rabbit (1981) (8)
Neuropeptide Y-like immunoreactivity of plasma during hypoglycaemia in man. (1989) (8)
Midline B3 Serotonin Nerves in Rat Medulla are Involved in Hypotensive Effect of Methyldopa (1986) (8)
Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial (2019) (8)
Sex differences in treatment, radiological features and outcome after intracerebral haemorrhage: Pooled analysis of Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage trials 1 and 2 (2020) (8)
Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial (2015) (8)
Intensive glucose‐lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial (2019) (8)
Cardiac performance in the conscious rabbit with acute hypertension following brainstem lesions coinciding with the A1 group of catecholamine neurons. (1984) (8)
Enthesopathy as the presenting feature of X-linked hypophosphatemia. A case report. (1993) (7)
Measurement of myocardial contractility in conscious rabbits. (1984) (7)
Cross-over factorial studies with antihypertensive drugs. (1987) (7)
Prevalence and risk factors of prediabetes after renal transplantation : a single-centre cohort study in 200 consecutive patients (7)
More on Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. (2018) (7)
LESIONS OF THE VENTROLATERAL MEDULLA IN NORMAL AND VASOPRESSIN‐DEFICIENT (BRATTLEBORO) RATS (1984) (7)
The ABCD of anti-hypertensive therapy? (2002) (7)
Blood pressure burden: vascular changes and cerebrovascular complications. (2000) (7)
Marital interaction and adjustment in patients with essential hypertension. (1983) (7)
Strategies to meet the need for long-term data (2016) (7)
ACCURACY OF THE TAKEDA TM‐2420 AMBULATORY BLOOD PRESSURE MONITOR (1989) (7)
Predicting the Effects of Blood Pressure–Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes MellitusNovelty and Significance (2015) (7)
The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes Mellitus (2014) (7)
Studies in ‘Quality’ Part-time Employment (2005) (7)
Estimating met demand for alcohol and other drug treatment in Australia. (2016) (7)
Hypertension in the elderly: benefits of treatment. (1995) (7)
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
Endothelin‐1 Causes a Biphasic Response in Systemic Vasculature and Increases Myocardial Contractility in Conscious Rabbits (1994) (7)
Risk factors and consequences of decreased kidney function in nursing home residents: A longitudinal study (2017) (7)
Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients with Type 2 Diabetes. (2020) (7)
The management of blood pressure in acute stroke (2003) (7)
Medicinal cannabis in Australia – Framing the regulatory options (2015) (7)
ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes. (2006) (7)
Schools of the foothills province : the story of public education in Alberta (1968) (7)
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study. (2019) (6)
Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk. (2017) (6)
1991 Guidelines for the prevention of hypertension and associated cardiovascular disease (1992) (6)
The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial (2020) (6)
Lowering blood pressure in 2003 (2003) (6)
Economic Evaluation of a New Polygenic Risk Score to Predict Nephropathy in Adult Patients With Type 2 Diabetes. (2020) (6)
The market for crystalline methamphetamine in Sydney, Australia (2009) (6)
Withdrawal of active treatment after intracerebral haemorrhage in the INTERACT2 study (2017) (6)
Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us. (2001) (6)
Demethylation of 3-O-methyldopa. (1971) (6)
Slow-release nifedipine as a single or additional agent in the treatment of essential hypertension--a placebo-controlled crossover study. (1985) (6)
Physical barriers and risks in basic activities of daily living performance evaluation in state housing for older people in Chile (2013) (6)
Examining supply changes in Australia's cocaine market. (2012) (6)
A review of the weight loss interventions for obese people with non-insulin-dependent diabetes mellitus (1995) (6)
The treatment of hypertension. (2003) (6)
New approaches to the study of bulbospinal (B3) serotonergic neurons in the control of blood pressure. (1985) (6)
Intensive versus guideline‐recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: The ENCHANTED trial (2020) (6)
Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries (2020) (6)
Eff ects of fi brates on cardiovascular outcomes: a systematic review and meta-analysis (2010) (6)
New insights from ADVANCE (2007) (6)
Blood Pressure Lowering In Diabetes: A Brief Review Of The Current Evidence And Description Of A New Trial (2001) (6)
Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol (2020) (6)
TACHYCARDIA AFTER GLUTAMATE INJECTION IN RAT SPINAL CORD IS NOT BLOCKED BY KYNURENATE OR MIMICKED BY METABOTROPIC AGONISTS (1996) (6)
Cardiovascular effects of intracisternal 6-hydroxydopamine and of subsequent lesions of the ventrolateral medulla coinciding with the Al group of noradrenaline cells in the rabbit. (1985) (6)
Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke (2021) (6)
A metastasing chordoma: a further note. (1972) (6)
COMPARATIVE HAEMODYNAMIC EFFECTS OF VERAPAMIL, FLECAINIDE, AMIODARONE AND SOTALOL IN THE CONSCIOUS RABBIT (1994) (6)
Sex‐specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE‐ON study (2020) (6)
m-Health in Coronary Disease Preventive Care. (2015) (5)
Illuminating dark networks: a social network analysis of an Australian drug trafficking syndicate (2011) (5)
[ADVANCE study: objectives, design and current status]. (2003) (5)
Alcohol minimum unit pricing and socioeconomic status (2014) (5)
Opioid innervation of the caudal ventrolateral medulla is not critical for the expression of the aortic depressor nerve response in the rabbit. (1991) (5)
Smoking influences outcome in patients who had thrombolysed ischaemic stroke: the ENCHANTED study (2021) (5)
A conceptual schema for government purchasing arrangements for Australian alcohol and other drug treatment. (2016) (5)
Sex differences in predictors for cognitive decline and dementia in people with stroke or transient ischemic attack in the PROGRESS trial (2021) (5)
The use of free and fixed drug combinations to improve hypertension control in our populations. (1999) (5)
Central 5-hydroxytryptamine and tryptophan hydroxylase in hypertensive rats (1981) (5)
Cost-effective reduction in stroke: lessons from the Japanese hypertension detection and control program. (2012) (5)
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial (2021) (5)
Hypertension after brainstem (A1) lesions in normal rats and in rats with adrenalectomy, sympathectomy or diabetes insipidus. (1984) (5)
Ambient Temperature and Severity of Intracerebral Haemorrhage: The INTERACT1 Study (2014) (5)
Children in Social Research: Do Higher Payments Encourage Participation in Riskier Studies? (2019) (5)
Adrenaline neurons and PNMT activity in the brain and spinal cord of genetically hypertensive rats and rats with DOCA--salt hypertension. (1981) (5)
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes (2016) (5)
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor (2020) (5)
Leg oedema due to a rheumatoid cyst in the pelvis. (1992) (5)
Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage. (2019) (5)
Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke (2021) (5)
Children and young people’s decision-making in social research about sensitive issues (2020) (5)
Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials (2020) (5)
Measuring the Progressivity of the Pharmaceutical Benefits Scheme (2015) (5)
The effects of intracisternal 6-hydroxydopamine on the development of neurogenic hypertension in the rabbit. (1971) (5)
Embryonic hypothalamic tissue transplanted to the IVth ventricle of newborn Brattleboro rats (1984) (5)
Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study. (1997) (5)
Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. (2022) (5)
Assessing concordance between trends in high-level drug trafficking and other serious and organised crimes in Australia, 2005–2006 to 2014–2015 (2018) (5)
THE LAMBIE‐DEW ORATION (1970) (5)
Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295–303 (2015) (5)
The ADVANCE trial – Authors' reply (2008) (5)
Half a Citizen: Reflections on work and welfare in contemporary Australia. (2011) (4)
Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
Positive impact of the participation in the ENCHANTED trial in reducing Door-to-Needle Time (2017) (4)
Collaborative Governance in the Reform of Western Australia's Alcohol and Other Drug Sector (2016) (4)
Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial (2018) (4)
Relative roles of vagal and sympathetic effector mechanisms in the baroreflex control of myocardial contractility in conscious rabbits (2004) (4)
Endothelin-1 produces heterogeneous regional haemodynamic effects in conscious rabbits. (1996) (4)
Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: Results from a longitudinal cohort and mendelian randomization study (2022) (4)
DISTRIBUTION OF CATECHOLAMINE-CONTAINING CELL BODIES IN THE RABBIT HINDBRAIN: A STUDY USING FORMALDEHYDE-GLUTARALDEHYDE INDUCED FLUORESCENCE (1979) (4)
Associations of Early Systolic Blood Pressure Control and Outcome After Thrombolysis-Eligible Acute Ischemic Stroke: Results From the ENCHANTED Study (2021) (4)
History of lower-limb complications and risk of cancer death in people with type 2 diabetes (2021) (4)
Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies (2022) (4)
Altered Reflex Vasoconstrictor Function in the Rabbit After Specific Brain-Stem Lesions (1981) (4)
Diabetes: Glycemic control and outcomes in people with diabetes and CKD (2012) (4)
Why marry? : an economic analysis of the male marriage premium (2002) (4)
Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial (2008) (4)
1109Medication reminder apps to improve medication adherence in coronary heart disease patients (MedApp-CHD): a randomised clinical trial (2018) (4)
The UKPDS and The Legacy Effect - Editorial (2008) (4)
The post hoc use of randomised controlled trials to explore drug associated cancer outcomes: methodological challenges. (2013) (4)
Use of Antipsychotic Drugs by Elderly Primary Care Patients and the Effects of Medication Reviews: A Cross-Sectional Study in Sweden (2017) (4)
Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial (2017) (4)
Walking sticks used by elderly patients (1982) (4)
Blood pressure and stroke: a continuing debate. (2006) (4)
Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial (2021) (4)
Quantitative effects of timolol and hydrochlorothiazide on blood pressure, heart rate and plasma renin activity: results of a double-blind factorial trial in patients with essential hypertension. (1976) (4)
Endogenous opioids tonically inhibit the depressor neurones in the caudal ventrolateral medulla of rabbits: mediation through delta- and kappa-receptors. (1991) (4)
Effects of low dose perindopril-indapamide combination on blood pressure in Type 2 diabetes: the ADVANCE trial run-in phase (2005) (4)
Salt intake and dietary sources of salt on weekdays and weekend days in Australian adults (2018) (3)
Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage: INTERACT2 Study. (2021) (3)
Genome-wide association study of kidney function decline in individuals of European descent: the CKDGen Consortium. (2015) (3)
Antalya statement of the International Society of Hypertension on the prevention of blood pressure-related diseases (2008) (3)
Cost-benefit of outcome adjudication in nine randomised stroke trials (2020) (3)
1119 CORRELATION OF SALT INTAKE WITH KNOWLEDGE, ATTITUDES AND BEHAVIOURS IN AUSTRALIAN ADULTS (2012) (3)
OS 34-04 SAFETY OF EARLY INTENSIVE BLOOD PRESSURE LOWERING IN CEREBRAL SMALL VESSEL DISEASE AND CHRONIC KIDNEY DISEASE IN ACUTE INTRACEREBRAL HEMORRHAGE. (2016) (3)
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial (2021) (3)
Secondary prevention of stroke by blood pressure-lowering treatment (2006) (3)
Post-Hoc Subgroup Analysis of a Randomized Controlled Trial Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease: A (2010) (3)
Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies (2016) (3)
Author response for "Response of 1,5‐anhydroglucitol to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial" (2019) (3)
Trust, agency and control: Perspectives on methadone takeaway dosing in the context of the Victorian policy review. (2015) (3)
Development of blood pressure lowering therapy from trials to practice (2004) (3)
Multiple risk factor interventions and inflammatory biomarkers in high risk individuals with type 2 diabetes. (2012) (3)
Comparison of dye-dilution and flowmeter estimates of pulmonary valve incompetence in dogs. (1960) (3)
Rising Rates and Widening Socioeconomic Disparities in Diabetic Ketoacidosis in Type 1 Diabetes in Scotland: A Nationwide Retrospective Cohort Observational Study (2021) (3)
The pitfalls of prevalence estimation: the case of regular and dependent methamphetamine use in Australia (2018) (3)
The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports (2022) (3)
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials (2017) (3)
Circadian variation in clinical features and outcome of intracerebral hemorrhage: The INTERACT studies (2016) (3)
The HOT Study: design and cost of major blood pressure trials. (1994) (3)
Increased Noradrenaline (na) Concentration in Cerebellum and Spinal-Cord of Stroke-Prone Spontaneously Hypertensive Rats (1980) (3)
Disbound and Dispersed: The Leaf Book Considered (2005) (3)
The relationship between proteinuria and cardiovascular disease: a systematic review (2009) (3)
Blood pressure lowering for the prevention of first stroke (2002) (3)
The impact of baseline potassium intake on the dose–response relation between sodium reduction and blood pressure change: systematic review and meta-analysis of randomized trials (2021) (3)
Response to Comment on Hillis et al. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295–303 (2014) (3)
1118 QUANTIFYING SALT AND POTASSIUM INTAKE IN VICTORIAN ADULTS (2012) (3)
Case history notes designed as an aid to professional education. Metabolic cataract causing loss of vision in newly diagnosed insulin‐dependent diabetes mellitus (1995) (3)
Location and Unemployment (2004) (3)
Abstract 180: The Relation of Timing and Degree of Blood Pressure Control with Hematoma Growth - Secondary Analysis of The Interact2 Trial (2014) (3)
Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm (2020) (3)
INTRACISTERNAL 6-HYDROXYDOPAMINE (6-OHDA) AND 5,6 DIHYDROXYTRYPTAMINE (5,6-DHT) IN EXPERIMENTAL HYPERTENSION (1974) (3)
Messages from major trials (2006) (3)
The recent expansion in the Australian cocaine market: who are the new users and what are the harms? (2013) (3)
PLASMA NEUROPEPTIDE Y AND ATRIAL NATRIURETIC PEPTIDE CONCENTRATIONS IN MAN (1988) (3)
A LACK OF POTENCY FOR THE δ‐OPIOID ANTAGONIST NALTRINDOLE AFTER MICROINJECTION INTO THE ROSTRAL VENTROLATERAL MEDULLA OF RABBITS (1990) (3)
Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III (2008) (3)
Thiamine in our bread and wine (1991) (2)
The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: the impact of enhanced research infrastructure on trial metrics and patient outcomes (2019) (2)
Progress: Perindopril protection against recurrent stroke study: rationale, results and importance: perspective from the principle investigators (2003) (2)
Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension (2004) (2)
The predictive ability of different measures of kidney function: new data from the Progress study (2006) (2)
Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes. (2022) (2)
CANCER AND CHRONIC KIDNEY DISEASE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF 33,618 PARTICIPANTS (2014) (2)
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study. (2023) (2)
Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke (2019) (2)
Importance of cardiac pacing in the analysis of vagal and sympathetic contributions to baroreflex control of cardiac performance in the conscious rabbit. (1984) (2)
Comparison of ambulatory and clinic blood pressure targets in obese and non obese subjects: a high blood pressure research council of Australia initiative (2010) (2)
Is Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events? (2021) (2)
Audubon in Edinburgh (1993) (2)
Disabling employment policy (2002) (2)
Polygenic risk scores predict diabetic complications and their response to therapy (2019) (2)
EFFERENT MECHANISMS RESPONSIBLE FOR THE BRADYCARDIA PRODUCED BY LESIONS COINCIDING WITH THE A1 GROUP OF CENTRAL CATECHOLAMINE NEURONS IN THE CONSCIOUS RABBIT (1984) (2)
Issues in the development of new combinations of blood pressure lowering drugs (2010) (2)
Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study (2019) (2)
Teachers of the Foothill Province: The Story of The Alberta Teachers' Association (1968) (2)
Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. (1996) (2)
ALTERED CARDIAC NORADRENALINE STORES IN DOCA‐SALT HYPERTENSIVE RATS (1981) (2)
LONG-TERM PROGNOSTIC VALUE OF ASPIRIN NON-RESPONSIVENESS AND PLATELET REACTIVITY AFTER ACUTE VASCULAR EVENTS: A POPULATION-BASED PROSPECTIVE COHORT STUDY (2009) (2)
Correlation between fall in blood pressure and in vivo amine release after α-methylDOPA (1989) (2)
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry (2019) (2)
Northland: The Founding of a Wilderness School System. (1985) (2)
THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA (2009) (2)
How do Research Ethics Committee Members Respond to Hypothetical Studies with Children? Results from the MESSI Study (2022) (2)
Can blood pressure-lowering therapy reduce the risk of cognitive decline in the elderly? (2015) (2)
Cost-effectiveness of blood pressure lowering with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: A trial-based analysis using the advance study (2010) (2)
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes (2012) (2)
Human Research Ethics Committee Experiences and Views About Children’s Participation in Research: Results From the MESSI Study (2021) (2)
Trafficking in multiple commodities: Exposing Australia’s poly-drug and poly-criminal networks (2016) (2)
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390–398 (2021) (2)
Impact of Model Choice When Studying the Relationship Between Blood Pressure Variability and Risk of Stroke Recurrence (2021) (2)
Progress with Blood Pressure Lowering in the Secondary Prevention of Stroke (2002) (2)
Polygenic Risk Testing at the Time of Diagnosis of Diabetes Could Help Prevent Its Micro- and Macrovascular Complications (2018) (2)
Edinburgh Research Explorer Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes (2012) (2)
Proceedings: Effects of clondine on baroreflex arc in conscious rabbits and man. (1975) (1)
When Blood Pressure is Difficult to Control (1981) (1)
Afferent Inputs to Ventrolateral Medulla (1991) (1)
New approaches for the prevention of vascular disease in Type 2 diabetes (2008) (1)
Comparison of Long-Acting and Short-Acting Diuretics in Mild Essential-Hypertension (1980) (1)
PROGRESS in Blood Pressure Control for the Prevention of Secondary Stroke (2021) (1)
Cardiovascular risk in Type 2 diabetes – reflecting on the ADVANCE study (2009) (1)
Chapter 34 – Cerebrovascular Disease in Hypertension (2013) (1)
Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease (2006) (1)
The effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes mellitus according to baseline cardiovascular risk in the ADVANCE trial (2009) (1)
Are market mechanisms associated with alcohol and other drug treatment outcomes? (2021) (1)
Effect of baroreceptor deafferentation on central catecholamines in the rat. (1979) (1)
Blood pressure control after a stroke: a continuing challenge! (2015) (1)
Activation of spinal opioid receptors contributes to hypotension after hemorrhage in conscious rats. (1999) (1)
Abstract 204: Blood Pressure Reduction And Stroke Recurrence: The Progress Trial (2013) (1)
Blood pressure lowering in 2003 (2003) (1)
Erratum: Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: The perindopril protection against recurrent stroke study (PROGRESS) CT substudy in Japan (Hypertension Research (2004) vol. 27 (147-156)) (2004) (1)
Smartphone Apps to Improve Medication Adherence (2016) (1)
Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial (2009) (1)
Plasma lipidomic profiles in two large independent cohorts improve upon conventional risk factors to predict cardiovascular events. (2016) (1)
Audubon in Edinburgh and His Scottish Associates (2003) (1)
Blood pressure and cerebral ischemia (2014) (1)
Guidelines Under Fire Again! (2017) (1)
Case reports designed as an aid to professional education. Infection and diabetes: Fasciitis in a poorly controlled insulin‐dependent diabetic (1996) (1)
Blood pressure variability and the outcome in acute intracerebral haemorrhage: post-hoc analysis of the INTERACT2 randomised controlled trial. (2014) (1)
Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial (2012) (1)
Lacunar stroke in PROGRESS study (2004) (1)
PM082 Interventions to Improve Medication Adherence in Coronary Disease Patients: A Systematic Review of Randomised Controlled Trials (2016) (1)
Thiamine in our bread and wine (I: Reply) (1991) (1)
Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE. (2022) (1)
Guidelines under fire again! (2017) (1)
Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trial (2023) (1)
PLASMA ATRIAL NATRIURETIC PEPTIDE IS INCREASED DURING ATRIAL PACING IN CONSCIOUS RABBITS (1987) (1)
Hypertension in China: Data from the 4th national hypertension survey in China (2006) (1)
409-P: Cardiac Biomarkers and Incident Peripheral Arterial Disease (PAD) in Patients with Type 2 Diabetes in the ADVANCE Trial (2019) (1)
The 'high-risk' and 'mass' strategies for control of blood pressure. (1995) (1)
Cardiovascular risk management among female and male patients in Australian General Practice: the AusHEART study (2009) (1)
Cardiac-Performance Following Lesions of the Ventrolateral Medulla-Oblongata (a1 Cells) in the Rabbit (1983) (1)
Aspirin benefit increases as eGFR declines: Results from a randomised controlled trial in a hypertensive population (2010) (1)
Mobile Phone Usage Patterns in an Acute Coronary Syndrome Cohort (2017) (1)
Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress (2022) (1)
Are the effects of telmisartan more marked in hypertensive patients? (2014) (1)
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trial (2020) (1)
YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES. (2016) (1)
OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY (2016) (1)
CORRELATION BETWEEN 24-HOUR AND SPOT/VOID URINE SAMPLES FOR THE PURPOSE OF POPULATION SALT INTAKE ASSESSMENT (2013) (1)
Erratum to: Intensive glucose control and risk of cancer in patients with type 2 diabetes (2013) (1)
MEASURING AUSTRALIAN SALT INTAKES (2009) (1)
MORTALITY PATTERNS IN HYPERTENSION: PP.15.441 (2011) (1)
OE-144 Perindopril-based Blood Pressure lowering Reduces Major Vascular Events in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischaemic Attack(Preventive medicine/Epidemiology/Education-1 (H) OE24,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the J (2006) (1)
The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes (2013) (1)
Efficiency and acceptability of a fixed low-dose perindopril-indapamide combination (1999) (1)
Joint effects of blood pressure lowering and glucose control in the ADVANCE trial (2008) (1)
Stratified effects of blood pressure-lowering treatment on long-term blood pressure: an individual patient-level meta-analysis involving 50 randomised trials and 334,219 participants (2020) (1)
Blood pressure lowering and stroke prevention (2003) (1)
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons (2005) (1)
Round table 2 : World Health Organization-International Society of Hypertension versus United States guidelines on hypertension treatment : similarities and differences (1993) (1)
Half a Citizen (2020) (1)
Author response for "Observational analyses from ADVANCE and ADVANCE‐ON" (2019) (1)
Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality (2022) (1)
Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/H (2015) (1)
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials (2021) (1)
Using CART to identify prescribing thresholds for cardiovascular disease (2015) (1)
Older patients with type 2 diabetes derive substantial benefits from blood pressure lowering with perindopril-indapamide (2009) (1)
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of evidence available in 2007 (2008) (1)
Hypertension Guidelines: Timely New Initiatives from East Asia (2015) (1)
The involvement of catecholamines in the central connexions of arterial baroreceptor reflexes in the rat [proceedings]. (1979) (1)
Impact of various night-time period definitions on nocturnal ambulatory blood pressure (2022) (1)
Definition and classification of hypertension: the WHO criteria (2001) (1)
Blood pressure and stroke prevention (2002) (1)
Different and their Types of Centrally Acting Antihypertensives Targets in the Central Nervous System (1994) (1)
Correlation between fall in blood pressure and in vivo amine release after alpha-methylDOPA. (1989) (1)
6 Disinhibition of amino acid pathways contributes to elevated blood pressure in the spontaneously hypertensive rat (1993) (1)
Observational analyses from ADVANCE and ADVANCE‐ON (2019) (1)
OS 34-04 SAFETY OF EARLY INTENSIVE BLOOD PRESSURE LOWERING IN CEREBRAL SMALL VESSEL DISEASE AND CHRONIC KIDNEY DISEASE IN ACUTE INTRACEREBRAL HEMORRHAGE (2016) (1)
Regional Differences in Early BP Management After Acute Ischemic Stroke in the ENCHANTED International Randomized Controlled Trials (2021) (1)
Resting heart rate and risk of death and cardiovascular complications in patients with type 2 diabetes. (2011) (1)
Guidelines are of considerable value in the management of hypertension (2000) (0)
Is blood pressure lowering for secondary stroke prevention in the very elderly associated with a higher risk of adverse events (2018) (0)
Current issues with dual inhibition of the renin-angiotensin system. (2013) (0)
Results from ADVANCE: including the link between cognition and cardiovascular events (2009) (0)
Cardiovascular Endpoints [Invited lecture] (2003) (0)
The efficacy of lower blood pressure goals on the prevention of stroke in chronic kidney disease: data from the PROGRESS study (2007) (0)
OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY. (2016) (0)
Blood pressure - independent effects of drugs inhibiting the renin-angiotensin system (2005) (0)
[Plenary speaker] Optimal hypertension management with Preterax (2010) (0)
The Future of Hypertension Guidelines: Simplified Recommendations and Widespread Treatment (2010) (0)
Diabetes and Vascular Disease: A New International Trial (2003) (0)
High blood pressure: facts, fiction and the Franco-Australian connections. The III George Everard Memorial Oration (2007) (0)
Improving diabetic cardiovascular and renal protection: results of the ADVANCE study [Invited speaker] (2008) (0)
Blood pressue lowering for patients who have had a stroke - the PROGRESS trial. Symposium on Prevention and Treatment of Hypertension (2002) (0)
Abstract P031: Weight Changes and Their Predictors Among 11,140 Patients With Type 2 Diabetes in The Advance Trial (2012) (0)
Audit of mortality in type 2 diabetes mellitus (2001) (0)
Case history notes designed as an aid to professional education. Advanced diabetic microvascular disease secondary to impaired glucose tolerance (1993) (0)
[Role of diuretics in the treatment of hypertension: from large controlled trials to international guidelines]. (1996) (0)
High blood pressure Tobacco use High blood glucose Physical inactivity Overweight and obesity High cholesterol Unsafe sex Alcohol use Childhood underweight (2011) (0)
Renal outcome and microalbuminuria data from ADVANCE (2008) (0)
The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus (2012) (0)
Ace inhibition: more than just blood-pressure reduction (2000) (0)
Event rates in trials of patients with type 2 diabetes. (2010) (0)
ALLHAT & ANBP2: two major and important trials on antihypertensive therapy (2003) (0)
the association of sodium and potassium intake with obesity : T6:s28.33 (2014) (0)
Progress with stroke prevention. Satellite Symposium on Central Cardiovascular Control (2001) (0)
[Keynote speaker] Lowering blood pressure in diabetes: lessons from ADVANCE and ACCORD (2010) (0)
SAT-294 RANDOMISED EFFECTS OF INTENSIVE GLUCOSE-LOWERING THERAPY ON THE RISK OF MAJOR CLINICAL OUTCOMES IN TYPE 2 DIABETES ACCORDING TO eGFR AND UACR LEVELS (2019) (0)
Rationale for very low-dose combination therapy first-line (2002) (0)
Implications of modern diabetes practice on glycaemic control and frequency of hypoglycaemia (1995) (0)
Diuretics; a modern treatment option? Symposium on Treatment of Hypertension [Invited lecture] (2005) (0)
O079 Rapid blood pressure lowering in acute intracerebral haemorrhage: relationship of time and intensity of treatment on haematoma growth in the INTERACT2 trial (2014) (0)
Cognitive Function and Dementia in Hypertension: Epidemiologic and Therapeutic Aspects (2012) (0)
Introduction to ADVANCE. A Satellite Symposium on: ADVANCE: a new era in diabetes and hypertension (2008) (0)
Blood pressure & stroke prevention (2000) (0)
Preventing the growing burden of stroke (2002) (0)
Abstract 13812: The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus (2012) (0)
Making best use of combination therapy: Investigator Satellite on “New Strategies for control of Resistant Hypertension" [Invited speaker] (2013) (0)
Blood pressure lowering in patients with prior stroke (2006) (0)
How far to lower blood pressure in the long term, after a stroke? (2014) (0)
State of the Heart 2011, 45 & Up Cardiovascular Research Collaboration – an initiative of CVRN [Invited speaker] (2011) (0)
ADVANCE: Blood Pressure Lowering in Diabetes (2009) (0)
Central obesity markers, but not BMI, are associated with cardiovascular risk in type 2 diabetic patients: results from the ADVANCE study (2009) (0)
Main and ongoing results from ADVANCE and other large scale trials (2014) (0)
[Abstract] Comparison of various anthropometric indices as predictors of cardiovascular disease in patients with type 2 diabetes (2009) (0)
Impact of guidelines for managment of hypertension (2002) (0)
Triple combination in hypertension: from blood pressure control to cardiovascular protection - Satellite Symposium on Triple combination in hypertension – fulfilling new expectations. (2014) (0)
What we know from trials? Results from high risk hypertensive patients [Invited lecture] (2006) (0)
Microvascular outcomes in type 2 diabetes - Authors' reply. (2017) (0)
Abstract WP107: Early Recurrence of Ischemic Stroke in Alteplase-treated Patients: The ENCHANTED Study (2019) (0)
Is fixed-combination antihypertensive therapy needed in post-stroke patients? (2013) (0)
Improving glycaemic control in T1DM: the Fife Insulin and Food Education for Diabetes (FIFE Diabetes) structured education programme (2015) (0)
Association of HDL Cholesterol with Cancer Incidence in Type 2 Diabetes: A Case of Reverse Causality? (2012) (0)
Abstract WP390: Regional Differences in Blood Pressure Management After Acute Stroke in International Randomized Controlled Trials (2020) (0)
Abstract TP371: Adopting a Patient-centered Approach in Acute Stroke Trials With Utility-weighted Modified Rankin Scale Scores (2019) (0)
The challenge of new clinical developments. (1983) (0)
ADREM – Evaluating the effects of blood pressure and glucose lowering on vascular retinal disorders in patients with Type 2 diabetes mellitus (2005) (0)
Management of the global risk in hypertension. Risk stratication and initiation of therapy (1999) (0)
Abstract 18688: Plasma Lipid Profiling to Predict Cardiovascular Events in Type 2 Diabetes (2014) (0)
ADVANCE blood pressure lowering arm: morbidity/mortality results and implementation (2008) (0)
Inflammatory markers and the risk of vascular complications and mortality in type 2 diabetes mellitus (2013) (0)
SP311INFLUENCE OF RENAL IMPAIRMENT ON OUTCOME FOR THROMBOLYSIS-TREATED ACUTE ISCHEMIC STROKE: THE ENCHANTED TRIAL (2017) (0)
Racial and ethnic differences exist in terms of efficacy of different classes of anti-hypertensive treatment (2016) (0)
ADVANCE: Blood Pressure Lowering in Diabetes (Letter to the Editor) (2009) (0)
Acute Increase in Creatinine after Starting ACE Inhibitor and Vascular Events and Premature Death in Patients with Type 2 Diabetes—The ADVANCE Trial (2018) (0)
Better BP control or specific drugs for prevention of stroke [Invited lecture] (2003) (0)
Preface [to Clinical and Experimental Hypertension Vol. 26, Nos. 7 & 8, 2004. Papers from the Proceedings of the 5th WHO/ISH meeting on pathophysiology and prevention of hypertension and cardiovascular disease] (2004) (0)
Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target (2021) (0)
Targets for Diabetes [Invited speaker] (2011) (0)
ADVANCE rationale and study design (2001) (0)
ADVANCE Master Meeting I of the ADVANCE Glucose-Lowering Arm (2008) (0)
Management of Hypertensions; messages from recent trials (2008) (0)
Circulating bone morphogenetic protein-7 (BMP7) and transforming growth factor-B1 (TGFB1) predict renal endpoints in patients with type 2 diabetes in the ADVANCE trial (2012) (0)
Update on randomised, controlled trials on antihypertensive treatment (2003) (0)
Abstract TMP25: Effects of Age and Ethnicity on the Benefits and Risks of Low- versus Standard-dose Alteplase in Acute Ischemic Stroke Patients: The Enchanted Trial (2017) (0)
Current prescribing of Blood Pressure lowering and statin therapies in Australian general practice according to risk level using new guidelines for cardiovascular risk assessment (2009) (0)
[OP.4A.11] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE AND HYPERTENSION (2017) (0)
Guidelines for the treatment of hypertension in diabetes (1999) (0)
Erratum. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. Diabetes Care 2014;37:1353–1359 (2015) (0)
Triple combination in hypertension: from theory to clinical evidence [satellite symposium] (2014) (0)
Blood pressure lowering in diabetes: a high priority [Invited lecture] (2004) (0)
Rapid blood pressure lowering in acute intracerebral haemorrhage: relationship of time and intensity of treatment on haematoma growth in the INTERACT2 trial - O079 [abstract] (2014) (0)
Cotterall Memorial Oration: Stroke and blood pressure: prevention and treatment [invited speaker] (2016) (0)
Inflammatory Biomarker Levels and The Risk of Vascular Complications and Mortality in Type 2 Diabetes Mellitus (2013) (0)
Renal and microalbuminuria data from ADVANCE (2009) (0)
Design and results of PROGRESS study (2002) (0)
Blood pressure control: what does post management say about the future? (1999) (0)
Clinical implications of PROGRESS (2001) (0)
in people with type-2 diabetes : a prospective cohort study from ADVANCE Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk (2011) (0)
SAT-287 eGFR SLOPE AND THE SUBSEQUENT RISK OF CLINICAL OUTCOMES IN TYPE 2 DIABETES (2019) (0)
Treating high blood pressure (2014) (0)
Australian Guidelines [Invited plenary speaker] (2011) (0)
Cardiovascular risk reduction from HOPE to PROGRESS (2002) (0)
A7958 Prevalence and clinical characteristics of patients with treatment resistant hypertension by region: the spirit study (2018) (0)
Introduction: advances in the prevention of cardiovascular disease in patients with diabetes. (2008) (0)
68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL (2012) (0)
Rational basis for drug treatment of hypertension. (1981) (0)
The future scenario: treating hypertension or lowering blood pressure. Symposium on Proving the Benefits of Antihypertensive Therapy (2002) (0)
YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES. (2016) (0)
Stroke: Blood pressure lowering in acute stroke—scant joy from SCAST (2011) (0)
Blood-pressure lowering in acute intracerebral hemorrhage. (2013) (0)
Could We Make Better Use of Raised Blood Pressure Readings in the Emergency Department? (2019) (0)
Hypertension and stroke prevention and WHO-ish Hypertension Guidelines and risk stratification (2000) (0)
BLOOD PRESSURE LOWERING WITH FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE PREVENTS DEATH AND VASCULAR EVENTS IN TYPE 2 DIABETES: THE ADVANCE TRIAL (2007) (0)
Realitites of multiple risk in cardiovascualr disease: "Introduction" and 'Inclusion" (2002) (0)
New results of the intensive Diamicron MR-based strategy (2009) (0)
Very low-dose combination therapy in the prevention of cardiovascualr mortality and morbidity in diabetics: ADVANCE (2001) (0)
ADVANCE study: morbidity and mortality results. Invited symposium presentation (2007) (0)
From the 31 st Annual Scientific Meeting of the High Blood Pressure Research Council of Australia (2009) (0)
Glycemic control and blood pressure control in type 2 diabetes [Invited keynote speaker] (2012) (0)
Sattar, N. (2018). Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE (2018) (0)
Perspectives and implications for practice. Symposium on ADVANCE: a step forward in Hypertension and Diabetes (2008) (0)
HDL Cholesterol is a Risk Factor for Diabetic Nephropathy But Not Retinopathy—Results From the ADVANCE Study (2011) (0)
ADVANCE - rationale, objectives and current status (2002) (0)
Main outcomes of blood pressure lowering and glucose control in ADVANCE (2008) (0)
Further advance in mortality reduction through triple combination (Satellite Symposium on “Meeting needs in Hypertension with a new three-drug fixed –dose combination"). (2013) (0)
ADVANCE - study design. Satellite symposium "Advances in treatment strategies of hypertension: a very low dose combination first line" (2001) (0)
Clincial trials are the gold standard (2000) (0)
Reductions in the risk of vascular events and stroke in patients with and without chronic kidney disease; new data from the PROGRESS trial (2006) (0)
[Keynote address] Management of Hypertension: Evidence from Clinical Trials (2009) (0)
Blood pressure lowering and secondary stroke preventio: overview of trials. Satellite Symposium on new Directions for Blood Pressure Control and Cardiovascular Protection in Stroke Prevention (2002) (0)
Do men and women respond differently to blood pressure lowering treatment? prospective meta-analysis of randomised trials (2008) (0)
Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (August 2009) (2009) (0)
The ADVANCE Morbidity – Mortality Study in Diabetes: current status and baseline data (2003) (0)
BLOOD PRESSURE-LOWERING, ANTIHYPERTENSIVE TREATMENT AND INCIDENT DIABETES (2021) (0)
Making good use of diastolic & systolic blood pressure in the management of hypertension. (Editorial). (2012) (0)
The Relative and Combined Ability of High Sensitivity Cardiac Troponin T and N-Terminal pro-BNP to Predict Cardiovascular Events and Death in Patients with Type 2 Diabetes Mellitus (2013) (0)
A factorial, randomised trial of blood pressure lowering and intensive glucose control in type 2 diabetes: new results fro ADVANCE (2008) (0)
Practical implications and implementation of PROGRESS: The PROGRESS results: comments and perspectives (2002) (0)
New perspectives - PROGRESS in the prevention of secondary stroke. Symposium on Stroke in the Elderly (2002) (0)
ADVANCE and glycaemia thresholds: a need to clarify the statistical approach. Reply to Currie CJ [letter] (2012) (0)
WHO-ISH Guidelines - Risk stratification as a guide to prognosis and treatment (1999) (0)
Epidemiology of cardiovascular disease (2002) (0)
RESTING HEART RATE AND THE RISK OF DEATH AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: 7E.03 (2011) (0)
Cardiovascular risk factor management in Australian General Practice (2009) (0)
Management of hypertension - 2004 [Invited lecture] (2004) (0)
Intensive Glucose Control and Blood Pressure Reduction Additive in Type 2 Diabetes Mellitus (2008) (0)
Supplementary Material for: Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage (2016) (0)
Hypertension: Common dilemmas in treatment (1981) (0)
Can NT-proBNP monitoring help prevent cardiovascular disease? Recent Advances in Cardiovascular Disease (2007) (0)
Prevention of cerebral ictus: the PROGRESS study. Symposium on Stroke Prevention (2002) (0)
STRATIFIED EFFECTS OF BLOOD PRESSURE-LOWERING TREATMENT ON LONG-TERM BLOOD PRESSURE: A META-ANALYSIS OF INDIVIDUAL-LEVEL DATA OF 334,219 PARTICIPANTS FROM 50 RANDOMIZED TRIALS (2021) (0)
New approaches to prevention of vascular disease in diabetes [Invited presentation] (2007) (0)
Original Investigation Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage (2016) (0)
Prevention of cardiovascular disease in type 2 diabetes : Design, recruitment and characteristics of 11,140 patients in the ADVANCE study (2004) (0)
Efficacy of low-dose vs standard dose rtPA between Asian and non-Asian participants with focus on stroke subtype and risk of intracerebral haemorrhage (2016) (0)
PDB54 ECONOMIC EVALUATION OF A NEW POLYGENIC RISK SCORE TO PREVENT NEPHROPATHIES IN TYPE-2 DIABETIC PATIENTS (2019) (0)
Prevention of Stroke and major cardiovascular events with perindopril-based treatment: The PROGRESS trial (2008) (0)
PP.16.103 FACTORS INFLUENCING THE AMBULATORY BLOOD PRESSURE RESPONSE TO LOW-DOSE ASPIRIN IN SUBJECTS WITH UNTREATED MILD HYPERTENSION (2018) (0)
ASSOCIATIONS OF EARLY BLOOD PRESSURE CONTROL AND OUTCOME IN THROMBOLYSIS-ELIGIBLE ACUTE ISCHAEMIC STROKE IN THE ENHANCED CONTROL OF HYPERTENSION AND THROMBOLYSIS STROKE STUDY (2019) (0)
Proceedings of the joint WHO/ISH symposium on hypertension and cardiovascular disease: Preface (1993) (0)
Fixed low dose combination therapies in hypertension (2000) (0)
ADVANCE - Rationale, study design and current status (2005) (0)
[Letter to the Editor] ADVANCE Blood pressure lowering in diabetes (2009) (0)
ALLHAT and the treatment of hypertension. (2003) (0)
Abstract 12172: HDL Cholesterol and the Risk of Microvascular Disease of Type 2 Diabetes (2012) (0)
Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial (2012) (0)
Secondary prevention: EUROPA in context of HOPE, PROGRESS and Heart Protection Study (2003) (0)
New Insights from ADVANCE – renal outcomes [Invited lecture in plenary session on Clinical Trials] (2008) (0)
Four presentations: (1) Debate on guidelines (2) PROGRESS (3) Blood pressure goals (4) Preterax (2000) (0)
PROGRESS in stroke prevention (2001) (2001) (0)
First line in hypertension: insight on diuretics (2003) (0)
Blood pressure and stroke prevention [Invited plenary lecture] (2004) (0)
Abstract TP362: Comparison of the Simplified Modified Rankin Scale Questionnaire With Conventional Neurological Scales in the Dose Arm of the Enchanted Study (2019) (0)
[Plenary presentation] Blood Pressure issues in patients with diabetes mellitus (2008) (0)
Advances in Type 2 Diabetes: ADVANCE: A new era in diabetes and hypertension (2008) (0)
[PP.13.01] THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER THERAPY IN PATIENTS WITH VASCULAR DISEASE (2016) (0)
Key findings in morbid-mortality trials with perindopril/indapamide fixed combination (2009) (0)
Opening address: Blood pressure & Stroke: perspective from Nara (2002) (0)
1645-P: Polygenic Risk Score for Prediction of Complications in Men and Women with Type 2 Diabetes (2020) (0)
OPTIMAL HYPERTENSION MANAGEMENT WITH PRETERAX: S3.1 (2010) (0)
Combination of blood pressure lowering drugs for better CVD protection (2009) (0)
Statistical analysis plan for the second INTEnsive blood pressure Reduction in Acute Cerebral hemorrhage Trial (INTERACT2): a large-scale investigation to solve longstanding controversy over the most appropriate management of elevated blood pressure in th (2013) (0)
Blood pressure arm results - Plenary session on “Hot topics in Diabetes”, devoted to ADVANCE-ON: post-trial observational study. (2014) (0)
The authors reply:. (2013) (0)
Pressure Variability and Outcome in Acute Ischemic and Hemorrhagic Stroke : A Post Hoc Analysis of the HeadPoST (2019) (0)
Invited talk on New Insights from ADVANCE: Blood pressure lowering and vascular disease in diabetes (2007) (0)
Interpretation and implications of PROGRESS. Plenary session (2001) (0)
The Johann Jacob Wepfer Award 2015 of the European Stroke Conference to Professor Ralph L. Sacco (2015) (0)
060 The Effects of Combination Blood Pressure Lowering in the Presence or Absence of Background Statin and Aspirin Therapy – a Combined Analysis of PROGRESS and ADVANCE (2020) (0)
Management of hypertension in stroke patients: primary and scondary prevention of stroke - the evidence from controlled trials of blood pressure reduction (2002) (0)
Relationship between ambulatory and clinic blood pressure: a high blood pressure research council of Australia initiative (2009) (0)
Journal of Hypertension. Introduction. (2007) (0)
Advance; Blood pressure lowering – background and rationale. Invitation to chair Satellite Symposium on ADVANCE. (2008) (0)
Risk factors and stroke prevention (2003) (0)
More on Salt - the China Salt Substitute Study [Invited lecture] (2004) (0)
ACE inhibitors: beyond hypertension: PROGRESS - clinical update (2002) (0)
Cerebrovascular Disease in Hypertension (2007) (0)
Vascular disease: a multifactorial problem (2004) (0)
BP Lowering Treatment Trialists Collaboration: Updates everyone should know (2008) (0)
PROGRESS - clinical relevance (2002) (0)
DOES USE OF ANTIHYPERTENSIVE TREATMENT TO REDUCE ALBUMINURIA TRANSLATE INTO EFFECTIVE BENEFITS ON OUTCOME AND MORTALITY? A REAPPRAISAL OF STUDIES WITH RENAL ENDPOINTS IN DIABETES: PP.16.105 (2010) (0)
Managing blood pressure: messages from recent trials (2007) (0)
Rationale, study design, study population (2007) (0)
Sulphonylurea‐induced hypoglycaemia in elderly people with diabetes (2021) (0)
Changes in Albuminuria and the Risk ofMajor (2017) (0)
Blood pressure and stroke prevention [Invited presentation] (2007) (0)
Blood pressure targets or goals - should they be achieved, and how? (2000) (0)
Short reports from PROGRESS, ADVANCE and BP Trialists [Invited speaker] (2011) (0)
HDL Cholesterol and the Risk of Microvascular Disease of Type 2 Diabetes (2012) (0)
The Cardiovascular Research Network (CVRN). (2011) (0)
Rationale, study design and study populations (2008) (0)
INTERACT2 Results: Intensive BP Lowering Safe and Effective in Acute ICH Patients (2013) (0)
Abstract T P228: Greater Effect of Early Intensive Blood Pressure Lowering on Hematoma Growth in Non-Chinese Participants in the Interact2 Trial (2014) (0)
The prevention of secondary stroke, cardiac outcomes and cognitive decline in patients with cerebrovascular disease: The PROGRESS trial (2003) (0)
Abstract P274: Kidney Filtration Markers and the Risk of Clinical Outcomes in Individuals With Type 2 Diabetes in the Advance Trial (2020) (0)
Long term effects of blood pressure lowering in type 2 diabetes: ADVANCE-ON, a 6 year post-trial follow-up of the ADVANCE trial. (2014) (0)
Blood pressure independent effects of inhibitors of the renin angiotensin system [Invited lecture] (2005) (0)
Regional Variations in Case Fatality following a Major Coronary or Cerebrovascular Event in People with Type 2 Diabetes—Evidence from the ADVANCE Trial and TECOS Trial (2018) (0)
ADVANCES from new trials in diabetes (2008) (0)
Mortality patterns in hypertension [Invited speaker] (2011) (0)
PROGRESS in stroke prevention. 'Hot Line' Symposium on Clinical Trials (2001) (0)
Options for Clinical Services: Provision of renal prevention and treatment services (2003) (0)
Supplementary Material for: Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial (2016) (0)
Chapter 9: Renal and microalbuminuria data from ADVANCE (2009) (0)
Type 2 Diabetes Mellitus Resting Heart Rate and the Risk of Microvascular Complications in Patients With Copyright (2012) (0)
EFFECTS OF BLOOD PRESSURE-LOWERING ON CANCER RISK: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF 300,000 PARTICIPANTS (2021) (0)
High sensitivity cardiac troponin T and N-terminal pro-BNP predict cardiovascular events and death in patients with type 2 diabetes mellitus (2013) (0)
Diabetes and hypertension: Is double therapy useful? (2016) (0)
Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
Clinical implications of PROGRESS: questions and answers (2003) (0)
Reductions in alanine aminotransferase levels with liraglutide treatment are greatest in those with raised baseline levels and are independent of weight loss: real-world outcome data from the ABCD Nationwide Liraglutide Audit (2019) (0)
Perindopril-based blood pressure lowering reduces major vascular and bleeding events in patients with cerebrovascular disease who use antithrombotic therapy: the PROGRESS trial (2011) (0)
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials (2021) (0)
Response to Letter by Kerr and Nasco (2009) (0)
New perspectives in the treatment of the diabetic patient - The ADVANCE Study (2007) (0)
Effects of blood pressure levels at presentation and those achieved during the first 24 hours on haematoma growth in acute intracerebral haemorrhage: the INTERACT trial (2010) (0)
The PROGRESS trial and the prevention of recurrent stroke. Symposium on Clinical Trial Updates and Late Breakers (2002) (0)
Lower blood pressure and the risk of recurrent stroke in patients with chronic kidney disease: results of the PROGRESS trial (2008) (0)
Abstract MP3: Low Dose versus Standard Dose Alteplase in Acute Lacunar Ischemic Stroke (2021) (0)
Opportunities for the control of pre-existing cardiovascular disease (2002) (0)
New Results from ADVANCE (2009) (2008) (0)
Abstract WMP85: Significance of Cerebral Small Vessel Disease in Acute Intracerebral Hemorrhage: The INTERACT2 Study (2016) (0)
Rational choice of drugs to lower blood pressure: evidence from clinical trials and from the Blood Pressure Trialists’ Collaboration (2009) (0)
Recent evidence from randomised clinical trials for the treament for hypertension (2003) (0)
Usefulness of various systolic BP variability parameters in predicting outcome in acute intercerebral haemorrhage: analysis of the INTERACT2 study (2014) (0)
The latest reconsideration for initial pharmacological therapy [Invited lecture] (2003) (0)
Clinical predictors of ACE-inhibitor induced dry cough in 27492 patients with cardiovascular disease using individual data of randomized clinical trials (2013) (0)
Abstract WMP91: Hyponatremia is Associated with Higher Mortality in Intracerebral Hemorrhage: Interact 1 and 2 Pooled Analysis (2016) (0)
Blood pressure lowering and glucose control in patients with type 2 diabetes (2009) (0)
Abstract TMP15: Asian versus Non-Asian, Differences in Characteristics, Management & Outcomes in the Enchanted Trial (2020) (0)
Abstract P209: Effects of Blood Pressure Lowering on Vascular Outcomes in Different Cardiovascular Risk Groups Among Patients With Type 2 Diabetes: New Results From Advance (2012) (0)
Cognitive function and risk of cardiovascular disease and hypoglycaemia among patients with type 2 diabetes in ADVANCE (2009) (0)
[Plenary Talk] ADVANCE: Management of Hypertension; messages from recent trials (2008) (0)
Hypertension and stroke prevention (2000) (0)
Hypertension and stroke prevention trial results (2003) (0)
SUN-161 CIRCULATING AUTOANTIBODIES TO ERYTHROPOIETIN RECEPTOR AND KIDNEY DISEASE PROGRESSION IN TYPE 2 DIABETES MELLITUS: RESULTS FROM THE ADVANCE STUDIES (2020) (0)
Blood pressure & kidney disease in Type 2 Diabetes: Evidence from ADVANCE [Invited speaker] (2011) (0)
MEASUREMENT OF MEAN ARM PRESSURE FOR CALCULATION OF CENTRAL AORTIC SYSTOLIC AND PULSE PRESSURE (2010) (0)
Cardiovascular epidemiology in East and West: Observational evidence from APCSC Collaboration and PROGRESS trial: Focus on Blood Pressure [Invited speaker] (2012) (0)
Lower target blood pressures would likely be safe and effective for the prevention of recurrent cerebrovascular disease (2005) (0)
ADVANCE Study: from clinical evidence to new perspectives in the treatment on hypertensive type 2 diabetes patients [Satellite Symposium - Invited speaker] (2008) (0)
Report from the "National Heart, Stroke and Vascular Health Strategies Group" (2004) (0)
Figure e-1, Figure e-2 (2018) (0)
Satellite Symposium on Prevention of vascular complications of diabetes: results from the ADVANCE study. Presentation on ADVANCE Rationale, Design & Population at Baseline (2007) (0)
Epidemiology of blood pressure in acute stroke [Invited speaker] (2011) (0)
Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study (2023) (0)
Impact of strict glucose control on macrovascular outcomes in type 2 diabetes [Invited keynote speaker] (2011) (0)
Management of chronic kidney disease in Australian general practice (the AusHEART Study) (2010) (0)
Abstract translations from Symposium on Serotonin and Vascular Disease (2004) (0)
PROGRESS in the prevention of stroke and CVD: clinical experience with ACE inhibition across a wide range of BP levels (2002) (0)
Does blood glucose lowering reduce cardiovascular outcomes a perspective on the trials (2009) (0)
Glycaemic control in group 2 license holders with diabetes mellitus (2018) (0)
[Plenary session] ADVANCE Trial – Study Results’. Summary of blood pressure lowering arm results (2008) (0)
Ambient temperature on severity and haematoma volume in acute intracerebral haemorrhage: the INTERACT 1 study (2013) (0)
70 17q21.31 CNV DOSE DEPENDENT EFFECT ON THE PREVALENCE OF HYPERTENSION AND DYSLIPIDEMIA COMORBIDITY (2012) (0)
The Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT): progress and challenges (2018) (0)
1102 – CARDIAC HISTAMINE AND NORADRENALINE IN SPONTANEOUSLY HYPERTENSIVE RATS (1978) (0)
[Plenary Lecture] New results from ADVANCE: First presentation of joint effects of blood pressure lowering and glucose control (2008) (0)
Blood pressure and vascular complications of diabetes (2001) (0)
Connecting the dots: ongoing ace inhibition trials and what they can tell us (2000) (0)
The intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): Results of the vanguard phase (2008) (0)
Advances in reducing the burden of vascular disease in Diabetes [Invited speaker] (2010) (0)
Response to Comment on Ohkuma et al. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial. Diabetes Care 2017;40:1203–1209 (2018) (0)
Managing hypertension: messages from recent trials (2007) (0)
Cardiovascular risk perception and evidence–practice gaps in Australian general practice (2010) (0)
BURDEN OF DISEASE AND THE UNDERUSE OF EFFECTIVE STRATEGIES (2015) (0)
Afterword: In the no-standing zone (2020) (0)
Results of the ADVANCE study: benefit from intensive blood pressure control. Invited plenary lecture (2007) (0)
Book Review: Employment Contracts and Well-being among European Workers (2007) (0)
Gaston Bauer Lecture - PROGRESS in stroke prevention (2001) (0)
ADVANCE: New results from blood pressure lowering and tighter glucose control in type 2 diabetes. A Session on: Optimal blood pressure reduction/clinical trials (2008) (0)
The management of hypertension - messages from recent trials [Invited speaker] (2007) (0)
251-OR: Relationship of Short-Term HbA1c Change with Vascular Events, Severe Hypoglycaemia, and Mortality (2019) (0)
Blood pressure lowering treatment and the prevention of stroke in the diabetic patient (2004) (0)
Making good use of diastolic and systolic blood pressures in the management of hypertension. (2012) (0)
A12614 Predictors of severity of hypertensive response in acute intracerebral haemorrhage (2018) (0)
Secondary prevention of stroke. Symposium of ACE inhibition, vascular compliance and cardiovascular implications (1999) (0)
Special Report- Address given in the People's Great Hall in Beijing, People's Republic of China, on National Hypertension Day (1999) (0)
IMPACT OF SEIZURES AFTER THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE: THE ENCHANTED TRIAL (2017) (0)
O3-04-08 Effect of white matter lesions on incidence of dementia in patients with stroke (2006) (0)
Presidential symposium on hypertension and stroke. Introduction. (1994) (0)
ADVANCE Study: run-in data (2005) (0)
Audit of cardiovascular risk assessment in type 2 diabetic patients referred for insulin therapy: a cardiological perspective (2004) (0)
Exposing Australia’s poly-drug trafficking networks (2015) (0)
The development and feasibility of a composite score of echocardiographic indices that may stratify outcome in patients with diabetes mellitus. (2015) (0)
Clinical implications satellite symposium "PROGRESS in Stroke Prevention" (2001) (0)
Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR. (2010) (0)
Blood pressure reduction in acute stroke: an insight from new trials [Invited Speaker] (2013) (0)
Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
Abstract 55: Kidney Measures Beyond Conventional Risk Factors for Predicting Incident Cardiovascular Disease: A Collaborative Meta-Analysis of 16 Cohorts (2014) (0)
1A.09: DISTINCT GENETIC ARCHITECTURE OF RENAL IMPAIRMENT COMPONENTS IN TYPE 2 DIABETES WITHIN CAUCASIAN POPULATIONS OF CELTO-GERMANIC AND SLAVIC ORIGINS (2015) (0)
CLINICAL OUTCOMES AND PATIENT CHARACTERISTICS ACCORDING TO THE COMBINATION OF TEN-YEAR RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND SYSTOLIC BLOOD PRESSURE (2021) (0)
Rapid BP lowering in acute ICH: relationship of time and intensity of Rx on Haematoma growth in the INTERACT2 trial (2014) (0)
Comparing the direct route from unemployment to permanent work with the route via casual work (2000) (0)
8. Old Wine in a New Wineskin (1968) (0)
English Bookbinding Styles, 1450—1800: A Handbook. David Pearson (2006) (0)
Limited Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure Management: Insights From Two Randomised Clinical Trials (2022) (0)
Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure Management (2022) (0)
S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL (2023) (0)
Cumulative Systolic Blood Pressure Load and Risk of Cardiovascular Outcomes in Patients With Diabetes (2022) (0)
Author response for "Variability in eGFR and the risk of major clinical outcomes in diabetes: post‐hoc analysis from the ADVANCE trial" (2021) (0)
Effects of blood pressure lowering for the prevention of dementia: meta‐analysis of individual patient data from five seminal randomised controlled trials involving 28008 participants (2022) (0)
Values and ethics about income support (2020) (0)
Women ’ s Financial Independence : Australia in the 1980 s and 1990 s (2003) (0)
Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes (2022) (0)
Author response for "Biomarkers associated with early stages of kidney disease in adolescents with type 1 diabetes" (2020) (0)
Synchronising to the One Beat: Development of a State-Wide ECG Online Learning Module (2022) (0)
IDF21-0200 Data Linkage to Reduce Severe Hypoglycaemia (2022) (0)
S117 Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial (2022) (0)
Dietary salt intake and discretionary salt use in an Australian population sample: 2011 and 2014 (2016) (0)
Benefits of Intensified Reductions in Blood Glucose and in Blood Pressure for Patients with Type 2 Diabetes. (2022) (0)
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply. (2022) (0)
Glycemic excursions and subclinical cardiac damage in adults with type 2 diabetes: Results from the ADVANCE Trial. (2021) (0)
Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398. (2021) (0)
Positive impact of the participation in the ENCHANTED trial in reducing Door-to-Needle Time (2017) (0)
Research: Epidemiology Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: ﬁndings from the ADVANCE and ADVANCE-ON trials (2020) (0)
Social connections (2020) (0)
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD (2023) (0)
Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials (2023) (0)
Blood pressure meta-analysis highlights an implementation gap – Authors’ reply (2022) (0)
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials. (2022) (0)
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (0)
A comparison of structural features and vulnerability between government and nongovernment alcohol and other drug (AOD) treatment providers. (2021) (0)
Housing , Location and Employment authored (2003) (0)
HISTAMINE IN THE HEART AND SPINAL CORD OF HYPERTENSIVE RATS (1979) (0)
Histamine levels in brain, spinal cord and heart of genetically hypertensive rats (1979) (0)
Effects of intraventricular injections of histamine on arterial blood pressure and heart rate in conscious rabbits (1978) (0)
EFFECTS OF ENDOTHELIN‐1 ON ARTERIAL PRESSURE: A COMPARISON OF INTRAVENOUS AND INTRA‐ARTERIAL ADMINISTRATION IN CONSCIOUS RABBITS (1994) (0)
Working lives (2020) (0)
Methyldopa hypotension and ascending projections from midline serotonin (B3) cells in the medulla. (1985) (0)
Felodipine Monotherapy in Systolic Hypertension in the Elderly (2012) (0)
Poverty, deprivation, resilience (2020) (0)
969 – CENTRAL NORADRENALINE TURNOVER IN ANIMALS WITH EXPERIMENTAL HYPERTENSION (1977) (0)
Welfare as work: Dealing with Centrelink (2020) (0)
102 Evidence that serotonin and amino acid receptors in the spinal cord mediate pressor responses produced by stimulation of the rostral ventrolateral medulla in the area of the B3 serotonin‐containing cells in the rat (1988) (0)
Barriers to and support for working (2020) (0)
Housing (2020) (0)
Applying behavioral insights to increase rural and remote internships: Results from two Randomized Controlled Trials (2021) (0)
Second Annual Conference of the International Society for the Study of Drug Policy : April 3-4 2008 , Lisbon , Portugal (2008) (0)
How much do people need to live on?: The Budget Standards Project (1998) (0)
Do unemployed people move to job opportunities (2003) (0)
Effects of L-Dopa on Norepinephrine Meta (2016) (0)
The receiving end of welfare (2020) (0)
INTRODUCTION (2008) (0)
Interlude: They Rode with John (1968) (0)
Metabolic Disorders of Bone (1975) (0)
6. From Trade to Profession (1968) (0)
12. The Ultimate Weapon (1968) (0)
Interlude: Tribute to F. J. C. Seymour (1968) (0)
Tumors of Bone and Cartilage (1972) (0)
Heritable Disorders of Connective Tissue (1974) (0)
9. We Sinais Climb (1968) (0)
IV th Franco-Australian meeting on hypertension. Introduction. (2008) (0)
The transplantation of bone : an experimental study (1961) (0)
The Role of Government (1959) (0)
10. Now Lettest Thy Servant Depart (1968) (0)
The arthrodesis in the restoration of working ability. Edited George Chapchal. 245 × 170 mm. Pp. 233 xv, with 281 illustrations. 1975. Stuttgart: Thieme. DM.80 (1976) (0)
4. The Doleful Tale of the Bureau of Education (1968) (0)
The Settlement of the West and The Canadian West: Social Change and Economic Development (1978) (0)
PERIPHERAL COMPRESSION LESIONS OF THE ULNAR NERVE 792 THE JOURNAL OF BONE AND JOINT SURGERY (1998) (0)
Operating theatres. Funders keepers. (1997) (0)
14. New Brooms (1968) (0)
13. The Rift in the Lute (1968) (0)
Women in the Struggle: Gladys Maqolo (1987) (0)
11. The Blackstock Caper (1968) (0)
Effect of brainstem lesions on vagal and sympathetic contributions to baroreceptor control of heart rate (1982) (0)
Intravenous Labetalol in Accelerated Hypertension (1979) (0)
Points: Bone scintigraphy in benign bone disease (1984) (0)
Federal, provincial and territorial strategies for Canadian native education, 1960–1970 (1976) (0)
AMTEC '82: Still on the Right Track (1982) (0)
8. Optimal size of cuff bladder for indirect measurement of arterial pressure (1988) (0)
170. Doxazosin and atenolol in essential hypertension: a placebo-controlled factorial study evaluating comparative and combined safety and efficacy (1991) (0)
Lubrication and Wear in Joints (1970) (0)
The structure and biochemistry of cartilage. A. Serafini-Fracassini, Padua, and J. W. Smith, St Andrews. 240 × 160 mm. Pp. 236+vii. Illusrated. 1974. Edinburgh: Churchill Livingstone. £8 (1975) (0)
Orthopaedics during the past 25 years. (1980) (0)
Fatigue Fracture in the Femur (1967) (0)
An Institutional Perspective on Accreditation in Higher Education. (1972) (0)
William MacGillivray and his association with John James Audubon. (1990) (0)
3. Alarms of Struggle (1968) (0)
The ancillary workers' strike--the experience of the Brent Health District. (1979) (0)
Variations in advice on breast-feeding. (1992) (0)
Cardiovascular Reflex Function in the Rabbit Following Lesions of the Ventrolateral Medulla (1981) (0)
The Alberta diamond Jubilee (1979) (0)
Interview with John Chalmers, October 21, 1987 (1987) (0)
Featuring John Chalmers. (1991) (0)
Felodipine compared to prazosin as additional therapy to a beta-blocking drug. (1987) (0)
5. From Trade to Profession (1968) (0)
101 Hypotension and hypothalamic amine release and content after acute alpha‐methyldopa administration (1988) (0)
Central serotonergic neurons and experimental neurogenic and renal hypertension in the rabbit. (1975) (0)
Effects of brainstem lesions on the nasopharyngeal reflex in the conscious rabbit (1983) (0)
15. Under the Dome: Variations on a Theme (1968) (0)
7. The Teaching Profession Act (1968) (0)
A FIFTY-TWO YEAR FOLLOW-UP OF A CASE OF SIR HAROLD STILES. (1964) (0)
Importance of central catecholaminergic neurones in renal hypertension in rabbits. (1972) (0)
1. Necessity Most Imperious (1968) (0)
Felodipine Compared to Prazosin as Additional Therapy to a β‐Blocking Drug (1987) (0)
The Poor at School in Canada; Observational Studies of Canadian Schools, Classrooms and Pupils. (1970) (0)
18. The Flowering of the Sixties (1968) (0)
Subject Index, Vol. 47, 1987 (1987) (0)
16. A Home of Fairest Mould (1968) (0)
Diseases of Bones and Joints (1971) (0)
The management of bone metastases: orthopaedic procedures (1987) (0)
20. Glutamate in spinally projecting neurons of the rostral ventral medulla (1991) (0)
2. Where Your Beginnings Are (1968) (0)
Laird of the West (1984) (0)
Blood Pressure Management in the Chronic Post-Stroke Phase (2019) (0)
Introduction. Hypertension in patients with diabetes: can the treatment of macro and microvascular events be improved? Rational of the ADVANCE Study (2006) (0)
Blood pressure and cerebral ischemia: A continuing dilemma [editorial] (2014) (0)

This paper list is powered by the following services:

Other Resources About John Chalmers

en.wikipedia.org

What Schools Are Affiliated With John Chalmers ?

John Chalmers is affiliated with the following schools:

John Chalmers 's Academic­Influence.com Rankings